Rongshi Li is a Professor of Chemistry and Medicinal Chemistry, UNMC Center for Drug Discovery, Department of Pharmaceutical Sciences, College of Pharmacy; Cancer Genes and Molecular Regulation Program, Fred & Pamela Buffett Cancer Center; and Center for Staphylococcal Research, University of Nebraska Medical Center. Dr. Li spent 14 years in industry advanced from Scientist to Senior Vice President after postdoctoral training at University of California San Francisco. Dr. Li began his academic career in 2008 at H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida. In 2013, he was recruited to University of Nebraska Medical Center. Dr. Li received 2013 Grants Award, 2014 and 2016 New Inventions, and 2016 Distinguished Scientist Award. Dr. Li has published over 100 peer-reviewed articles, invited reviews, US and PCT patents, edited books, book chapters, and editorial. He delivered over 100 lectures and presentations in the universities and research institutions throughout the world, and in national and international symposia as invited and keynote speakers.

Chemistry and Medicinal Chemistry

Dr. Satinder Ahuja successfully managed development of many new drugs at Novartis Corporation for over 25 years in a number of leadership positions that led to earnings of billions of dollars. His expertise is recognized worldwide in chromatography and separations, especially in the area of ultratrace analyses, chiral separations, and characterization of contaminants by various techniques. As President of Ahuja Consulting, he has advised major pharmaceutical companies in the US and abroad on new drug development and on green chemistry solutions to environmental issues. He has given plenary lectures worldwide, won awards, and published numerous papers and over twenty books.

Ultratrace analyses

Wei Zhang, PhD Professor and Director of the Center for Green Chemistry Department of Chemistry University of Massachusetts Boston

Organic Chemistry and Green Chemistry

Wei Li, Ph.D. Professor and Faculty Director of Instrument Facility University of Tennessee Health Science Center. His research areas include drug-targeting, nanoparticles, drug transport across the blood-brain barrier using nanoparticles, microspheres, trans-dermal transport, polymeric drug delivery systems, adjuvants for vacccines, solid solutions, stability testing by microcalorymetry, and container materials. He has over 300 publications.

His research areas include drug-targeting, nanoparticles, drug transport across the blood-brain barrier using nanoparticles, microspheres, trans-dermal transport, polymeric drug delivery systems, adjuvants for vacccines, solid solutions, stability testing by microcalorymetry, and container materials. He has over 300 publications.

Carlos Feleder was selected by the Italian Ministry of Health to review grant applications for biomedical research. He reviews grants in the fields of neuroscience, immunology, and endocrinology. Dr. Feleder servers as a Principal Investigator at the Albany Center for Computational Nano-Neuroscience at The State University of New York. He has done his M.D. from School of Medicine, University of Buenos Aires, Buenos Aires, Argentina and completed his PhD. from The Frauenklinik fur Experimentelle Endokrinologie, University George-August, Gottingen, Germany; and Department of Physiology, School of Medicine, University of Buenos Aires, Argentina

Dr. Feleder has a long-standing interest in uncovering the mechanisms underlying the body's response to immune challenges, i.e., how the central nervous system controls the physiologic functions that protect the body from the harmful effects of infectious agents. In 2008, Dr. Feleder was awarded a three year research grant totaling $231,000 from the National Institutes of Health (NIH) to study the effects of the spleen in managing fever.

Asunción Barbero was born in Burgos, Spain. She studied Chemistry at the University of Valladolid, and received her PhD degree at the same university working with Prof. Pulido. She joined Prof. Ian Fleming’s group at the University of Cambridge as Marie Curie fello for two years working in the study of stereocontrol in organic synthesis using silicon chemistry. She came back to Valladolid as Assistant Professor, was promoted to Associate Professor in 2001 and obtained the spanish habilitation to full Professor in 2012. In 2013 she was appointed as Coordinator of the Grade of Chemistry of the University of Valladolid. She has co-authored around 50 international scientific publications and has delivered several invited and plenary lectures. Her current interests include the study of the silyl-cupration of multiple bonds and its application to the synthesis of natural and related products.

Organic synthesis, synthesis of heterocycles, Organometallic synthesis, Synthesis of carbocycles, synthesis of natural products

Research activities developed within Catherine Guillou’s group are centred on the development of new methodologies, their application to the total synthesis of biologically active natural products and the design of enzyme inhibitors involved in cancer and Alzheimer’s disease. She is co-authors of 58 publications and 8 patents.

Chemistry

Dr Guallar completed his PhD in collaboration between UAB (Spain) and UCBerkeley (USA) and postdoctoral studies from Columbia University. After an assistant professor position at Washington University School of Medicine (USA), he was awarded an ICREA professor position at the Barcelona Supercomputing Center. He is also founder of Nostrum Biodiscovery. He has published more than 100 papers in reputed journals and has been the recipient of presitioug grants like an Advanced ERC from the European Union.

Chemistry, Drug designing, High performance computing and improved 2D/3D visualization techniques.

Dr. Bhargava Karumudi is a research specialist at University of Illinois, Chicago in the field of medicinal chemistry. He has completed his postdoctoral in medicinal chemistry in 2014 at University of Illinois.

Organic Synthesis/Medicinal Chemistry, Chemical Biology, Chemistry of natural products with interesting biological activity, Natural products drug discovery, developing new probes to explore promising drug targets/photoaffinity labeling, LC-MS/MS.

Praveen S Hiremath is currently working as a Principal Scientist at Pharmaceutics International Inc Pii. He has completed Masters and doctoral studies and PhD in Pharmaceutics. Dr. Hiremath has worked in renowned Pharmaceutical companies like Astra Zeneca and Ranbaxy. Also he has Postdoctoral experience in Pharmaceutical drug delivery and formulation from Western University of Health Sciences, California, USA. Dr. Hiremath has published several research articles in peer reviewed international journals. He has extensively presented his research at international conferences/symposiums. Dr. Hiremath has been an invited speaker at international conferences. He has been invited to edit books in Pharmaceutical formulation and technology. Dr. Hiremath serves on editorial board of Journal of Bioequivalence and Bioavailability, Journal of Bioanalysis and Biomedicine and Research in Pharmaceutical Biotechnology. He is a full member of Sigma Xi Scientific Research Society and member of AAPS.

Oral drug delivery Pharmaceutical formulation development Controlled release drug delivery systems Pharmaceutical intellectual property (IP) Lipid based drug delivery systems Pharmaceutical technology Quality-by-design (QBD).

Dr. Sahar Ahmed is an Assistant Professor at the Department of Pharmacognosy and Pharmaceutical Chemistry, College of Pharmacy, Taibah University, KSA. She is Currently on leave from the Department of Medicinal Chemistry, Faculty of Pharmacy, Assiut University, Egypt. Dr. Ahmed received her B.Sc. from the Faculty of Pharmacy, Assiut University, Egypt, and then her M.Sc. From the same Faculty. She subsequently got her Ph.D. from the Faculty of Pharmacy, University of Alberta, Canada in 2010 under the supervision of Dr. K. Kaur followed by one year of a postdoc at the same Faculty. She has participated in many international conferences and published 15 publications in international journals and one chapter book.

Organic Synthesis/Medicinal Chemistry, Chemical Biology, Chemistry of natural products with interesting biological activity, Natural products drug discovery, developing new probes to explore promising drug targets/photoaffinity labeling, LC-MS/MS.

Daisuke Yamamoto has completed his PhD in 2006 at Kitasato University (Prof. Toshiaki Sunazuka). Subsequently, he became a researcher at the Kitasato Institute (Prof. Satoshi Ōmura) and joined the group of Prof. Barry M. Trost at Stanford University, as a postdoctoral fellow. In 2008, he started his academic career as an Assistant Professor at Kitasato University. His research focuses on the development of redox reactions with attendant applications in biologically active molecules.

Chemistry: development of redox reactions and applications in biologically active molecules

Vladimir P. Torchilin is a University Distinguished Professor and Director, Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston. He graduated from the Moscow University with MS in Chemistry, and obtained there his Ph.D. and D.Sc. in Polymer Chemistry and Chemistry of Physiologically Active Compounds in 1971 and 1980, respectively. In 1991, Dr. Torchilin joined MGH/Harvard Medical School as the Head of Chemistry Program, Center for Imaging and Pharmaceutical Research, and Associate Professor of Radiology. He was the Chair of the Department of Pharmaceutical Sciences in 1998-2008. His research interests include liposomes, lipid-core micelles, biomedical polymers, drug delivery and targeting, pharmaceutical nanocarriers, experimental cancer immunology. He has published more than 350 original papers (which received more than 30,000 citations), more than 150 reviews and book chapters, wrote and edited 10 books.

Research Interest including Immobilized Enzymes in Medicine, Targeted Delivery of Imaging Agents, Liposomes, Nanoparticulates as Pharmaceutical Carriers, Biomedical Aspects of Drug Targeting, and holds more than 40 patents. He is Editor-in-Chief of Current Drug Discovery Technologies and of Drug Delivery and on the Editorial Boards of many journals including Journal of Controlled Release (Review Editor), Bioconjugate Chemistry, Advanced Drug Delivery Reviews, Molecular Pharmaceutics.

Volkmar Weissig, Sc.D., Ph.D. is a Tenured Full Professor of Pharmacology and Chair of the Department of Pharmaceutical Sciences. Dr. Weissig received his B.S., M.S. and Ph.D. degrees in Chemistry and his postdoctoral Sc.D. degree in Biochemistry and Pharmaceutical Biotechnology from the Martin-Luther University in Halle (Germany). Combined he completed several years of postdoctoral fellowships at the Cardiology Research Center in Moscow (Russia), at the Academic Department of Medicine at the Royal Free Hospital School of Medicine in London (UK), at the Institute of Organic Chemistry at the Czechoslovakian Academy of Science in Prague (CSFR), at the College of Pharmacy and the College of Medicine at the University of Florida, Gainesville, FL and at Harvard Medical School and Massachusetts General Hospital in Boston, MA. Before joining the faculty at Midwestern University, Dr. Weissig was an Assistant Professor of Pharmaceutical Sciences at Northeastern University in Boston, MA. Dr. Weissig holds 16 patents and he has published 98 research papers, review articles and book chapters, mostly in the area of nano drug delivery systems. He also edited and published 8 books. He serves as the Associate Editor of the Journal of Liposome Research and he is member of several other Editorial Boards. In July 2009 Dr. Weissig was inducted into the World Technology Network as a Fellow. In October 2014 Dr. Weissig was elected President of the World Mitochondria Society.

Dr. Weissig’s major research interests lie in the areas of Mitochondrial Medicine and Pharmaceutical Nanotechnology. In particular, his laboratory has pioneered the design and development of mitochondria-targeted nano drug delivery systems, which have opened new strategies for mitochondrial gene therapy, for apoptosis-based anticancer chemotherapies and for controlling and manipulating the redox status of mammalian mitochondria.

Professor Raid Alany has over 25 years of international experience in pharmacy education, pharmaceutics and drug delivery research. His academic journey spans three continents, namely, Asia, Oceania and Europe. He received his PhD in drug delivery from the University of Otago, Dunedin New Zealand in 2001; was appointed as a Lecturer at the School of Pharmacy, The University of Auckland, Auckland, New Zealand. He joined Kingston University London as Professor (Chair) of Pharmaceutics in January 2011 and was appointed as Research Director for the School of Pharmacy and Chemistry in December 2013. Raid is an author on over 200 scientific research publications (papers and abstracts), a book and seven book chapters. Professor Alany acts as Editor-in-Chief for Pharmaceutical Development and Technology, Section Editor for Clinical and Experimental Ophthalmology the official journal of the Royal Australian and New Zealand College of Ophthalmologists; Chief Patron, Drug Development and Therapeutics, a publication of Organization of Pharmaceutical Unity with BioAllied Sciences (OPUBS). He serves on the Editorial Board of the following journals: Current Medical Research and Opinion, BioMed Research International, Journal of Drug Delivery Science and Technology, Current Drug Delivery, Pharmaceutics MDPI, and Drug Delivery Letters. He is the Immediate Past President of the New Zealand Chapter of the Controlled Release Society (NZCRS), Young Scientist Committee of the Controlled Release Society. Raid won several awards such as Microscopy New Zealand Young Scientists Award in 1999 The University of Auckland's Vice Chancellor's Early Career Research Excellence Award in 2003, the Controlled Release Society Veterinary Programme co-chair/ chair Distinguished Service Awards in 2008/2009 and the Spark Ideas Challenge, Uniservices Prize and Chiasma Prize in 2011. He consults for human and veterinary pharmaceutical companies in New Zealand and Singapore and is an inventor on several international patents.

Ophthalmic Drug Delivery; Lipid and Surfactant Based Drug Delivery Systems; Delivery of Antisense Oligonucleotides and siRNA; In Situ Gelling Systems; Veterinary Pharmaceuticals

Arwyn gained his PhD in protein biochemistry and crystallography at Birkbeck College, University of London. Then he undertook postdoctoral positions investigating endocytosis at the University of Liverpool and Harvard University, Boston USA. In 2000 he was awarded a European Molecular Biology Organization fellowship to work at the European Molecular Biology Laboratory (EMBL), Heidelberg Germany, and continued at the EMBL when he was awarded an Alexander von Humboldt Foundation Scholarship. He was appointed as Lecturer at the Cardiff School of Pharmacy and Pharmaceutical Sciences at Cardiff University in 2002 where he is now a Professor in Membrane Traffic and Drug Delivery. In addition to scientific research, Arwyn also has a very wide interest in public engagement with science and has organised a number of large exhibitions focusing on e.g. stem cell biology, tissue engineering, pollination and neuroscience. Through a BBC scholarship, he gained a Diploma in Journalism qualification from Bangor University in 2001 and for a number of years he has been a regular face and voice in the Welsh media discussing scientific issues.

Projects in his lab fall under cancer cell biology, endocytosis and drug delivery, concentrating on linking endocytosis research to enhance our capacity to deliver therapeutics to defined regions of cells. He actively collaborates with a number of national and international groups including his recent strong involvement with COMPACT (http://www.compact-research.org/) - an academic/industrial consortium collaborating on the Optimisation of Macromolecular Pharmaceutical Access to Cellular Targets. Arwyn has published widely within the fields of endocytosis and drug delivery especially within the remit of early endosomal traffic and the utilization of Cell Penetrating Peptides as drug delivery vectors. He currently sits on the Editorial Board of the Journal of Controlled Release and Membranes.

Amiram Goldblum is the Head of the Molecular Modeling and Drug Design and Discovery Unit at the Institute for Drug Research of the Hebrew University. Following a BSc in Chemistry and Physics and a MSc in QM studies of molecular spectra, his PhD is in Organic Reaction Mechanisms (Mechoulam, Hebrew U). He completed his Post-doctoral studies of Quantum Biochemistry (Paris), QSAR and QM reaction mechanisms (California). He receieved his first award at the American Chemical Society National Meeting in Washington DC 2000 for his algorithm called "Iterative Stochastic Elimination" (ISE) used to solve extremely complex combinatorial problems and focuses in recent years on Molecular Discovery by Chemoinformatics.

Computational methods for Drug Delivery Systems

Gabriele Sadowski is full Professor for Thermodynamics. Her main fields of research are thermodynamics of biological and pharmaceutical systems. She has published about 150 papers, is Chair of the German Working Party of Thermodynamics and member of the German Academy of Technical Sciences. 2011, she received the prestigious Leibniz award.

Thermodynamics of Biological and Pharmaceutical systems.

Costas Kiparissides is a full time Professor of Chemical Engineering Department (AUTH) since 1981. He was Director of CPERI (2001-2006) and CERTH (2005-2010). He received his diploma in Chemical Engineering from NTUA (1971) and his Ph.D. from McMaster University (1978). He has supervised more than fifty Ph.D. students, 160 diploma theses and has presented more than 300 invited seminars and lectures. He has published 210 papers in refereed journals, 430 conference papers and 24 books and reports. His research interests include advanced multi-scale modeling of chemical and biological systems, functional materials, drug delivery systems, and microbial production of functional biopolymers.

Pharmaceutics and Novel Drug Delivery Systems

Mino Caira has directed the Centre for Supramolecular Chemistry Research at the University of Cape Town (UCT) since 2005. He retired as Professor of Physical Chemistry in 2014 and was subsequently appointed as a Senior Scholar in the Department of Chemistry at UCT. His expertise is in the area of solid-state chemistry of drug polymorphs and novel multi-component systems containing active pharmaceutical ingredients. He has published over 300 papers in international journals and since 2009 has served on the Editorial Advisory Board of the Journal of Pharmaceutical Sciences.

Crystalline supramolecular systems containing drug molecules and Drug Delivery Systems

B. B. Barik has completed his Ph.D. in 1993 from Jadavpur University, Kolkata, India. He is the Professor in the department of Pharmaceutics, College of Pharmacy, Jazan University, KSA. Earlier he worked as professor and head in the Univ Dept of Pharm Sci, Utkal University, Bhubaneswar, India and College of Pharmaceutical Sci, Berhampur, Odisha. He has published more than 50 papers in reputed journals and presented more than 100 papers in national and international conferences. He is serving as reviewer and editorial board member of reputed journals.

Novel Drug Delivery and Pharmaceutics

Şennur Görgülü Kahyaoğlu has completed her MSc degree from Anadolu University Department of Advanced Technologies-Biotechnology and continued Doctoral studies at the same University Graduate School of Health Sciences, Department of Pharmacology. She is responsible for xCELLigence RTCA MP System, flow cytometer, confocal microscope and cell culture laboratory. She is pursuing her studies on nano-biotechnology for novel drug research and development. She has 3 papers in refereed journals and has attended more than 15 conferences.

Pharmaceutics and Novel Drug Delivery Systems

Bahar Demir has graduated from Eskişehir Osmangazi University Department of Biology. She is doing her Post-graduation at Anadolu University Department of Biochemistry. She is studying on anti-cancer agents for novel drug research and development. She has taken part in 2 projects and has attended more than 5 conferences.

Pharmaceutics and Novel Drug Delivery Systems

Meliha Ekinci received her Master’s degree in Radiopharmacy from Ege University (Turkey) in 2015. She is currently a Research Assistant at Radiopharmacy Department and also a Doctoral student at Biopharmaceutics and Pharmacokinetics Department, Ege University. She has already published 4 papers in reputed journals. Her research interest is in radiolabeled and evaluated newly developed radiopharmaceuticals for diagnosis of different cancer types.

Pharmaceutics and Novel Drug Delivery Systems

Nehal has got her Master’s degree in Pharmaceutical Chemistry from the German University in Cairo in 2015. She is currently working as a Research Assistant in Zewail City of Science and Technology. Moreover, Nehal is a Drug Design Ph.D. student in Zewail City. She has 2 publications in reputable international journals as well as an accepted Poster in another international conference.

Pharmaceutics and Novel Drug Delivery Systems

Sahar Awwad completed both her Bachelor’s in Pharmacy and MSc in Drug Delivery. She is in the final year of her PhD at UCL School of Pharmacy and UCL Institute of Ophthalmology, under the supervision of Professor Steve Brocchini and Professor Sir Peng Tee Khaw.

Pharmaceutics and Novel Drug Delivery Systems

Merari Tumin Chevalier has completed a 5 years degree in Chemistry from National University of Mar del Plata. Currently, she is working on her PhD thesis at the Research Institute in Materials Science and Technology (INTEMA)- CONICET (Argentina), particularly in the Group of Polymer Matrix Composite Materials led by Dra. Vera Alvarez. The goal of her work is to develop and study effective biopolymeric drug carriers. At the present time, she is doing a six month residence in the Polymer Science and Technology Institute (ICTP)-CSIC (Madrid) in order to acquire new knowledge regarding the preparation and characterization of polymeric nanoparticles.

Pharmaceutics and Novel Drug Delivery Systems

Shayan F Lahiji has completed his BS and MS from Yonsei University (South Korea) and is currently doing his PhD at the same university. Because of his outstanding contribution to science and new novel delivery systems, he has been awarded in different fields of science for “The best poster presenter” from 3rd world biotechnology conference, “The best research award” from Yonsei University and “The best academic poster” from BK21 PLUS Research Symposium and more. He has published papers in reputed journals such as “Scientific Reports” from Nature Publishing Group and “Biomaterials” from Elsevier.

Pharmaceutics and Novel Drug Delivery Systems

Jesus Izaguirre Carbonell obtained his degree in pharmacy at Universidad Miguel Hernandez in Spain. Thereafter, he moved to Japan where he is currently completing his PhD at Tokyo University of Science under Prof. Sugawara supervision and where he also obtained his master degree. He has published 4 papers for obtaining his PhD degree including renowed journals.

Pharmaceutics and Novel Drug Delivery Systems

N Storozhylova is a Erasmus Mundus NanoFar PhD student at University of Nantes and University of Santiago de Compostela, 2013-2016.

Pharmaceutics and Novel Drug Delivery Systems

Dr. Janis Gravitis gained his PhD and DocSci from the the fomer USSR Academy of Science. Author and co-author of more than 300 scientific publications. Visiting Professor at the United Nations University, Institute of Advanced Studies, Tokyo, Japan, 1996–2000 Fellow of the International Academy of Wood Science Foreign Member of the International Research Centre for Sustainable Materials (Tokyo) Head of the Laboratory of Biomass Eco-Efficient Conversation, Latvian State Institute of Wood Chemistry - recently.

Wood Chemistry, Biomass Eco-Efficient Conversation, Green Chemistry

1978 and 1999 has completed his Ph.D and D.Sci. at the ages of 33 and 54 years from Zelinsky Instiute of Organic Chemistry, Moscow, Russia and Durmishidze Institute of Biochemistry and Biotechnology, Tbilisi, Georgia, respectively. 2006 up to date he is the head of laboratory of plant biopolymers at the Tbilisi State Medical University Institute of Pharmacochemistry. 1996 and 2002 he has been a visiting scientist at Utrecht University (faculty of pharmacy), The Netherlands, by University Scholarship and The Netherlands organization for scientific research (NWO) Scholarship Scientific Program, respectively. He has published more than 80 papers in reputed journals.

Biochemistry, biotechnology,biopolymers, Pharmacochemistry and pharmacy

Maia Merlani has completed her PhD at the age of 27 years from Tbilisi State University. She is Senior Research Scientist at Tbilisi State Medical University and at the same time holds a position of an associate professor at Caucasian International University. Her field of interest is a chemistry and synthesis of natural compounds. She is the author of more than 45 papers in reputed journals and presentations at 55 international scientific conferences. She was granted Georgian Presidential scholarship for young scientists (1997), NATO scholarship (2002) and Matstumae International foundation scholarship (2013).

Chemistry and synthesis of natural compounds

Radovan Buffa has completed his PhD in 2002 from Comenius University in Bratislava, Slovakia and postdoctoral studies from ETH Zurich, Switzerland. Last 7 years he is the head of the Department of Chemical modification in the Contipro Pharma Company, Czech Republic. He has published more than 15 papers in reputed journals and he is author/co-author of more than 20 patents.

Chemistry and Pharmacy

Daniel T Gryko obtained his PhD from the Institute of Organic Chemistry of the Polish Academy of Sciences in 1997, under the supervision of Prof. J. Jurczak. After a Postdoctoral stay with Prof. J. Lindsey at North Carolina State University (1998–2000), he started his independent career in Poland. He became Full Professor in 2008. The same year he received the Society of Porphyrins and Phthalocyanines Young Investigator Award. His current research interests are focused on the synthesis of various functional dyes as well as on two-photon absorption, artificial photosynthesis, excited-state intramolecular proton transfer and fluorescence probes.

Organic Chemistry

Halina Abramczyk has completed his PhD from Technical University of Łódź, Poland, postdoctoral studies from Bielefeld University, Germany, and habilitation from Technical University of Łódź. She is the director of Laboratory of Laser Molecular Spectroscopy, Łódź University of Technology. He has published more than 190 papers in reputed journals, 7 books or chapters in books and has been serving as an editorial board member of Journal of Molecular Liquids. She has received a number of awards including the Marie Curie Excellence Chair, Fulbright, DAAD. She is a President of Polish Fulbright Alumni Association. She was a head of Marie Curie Excellence Chair, Max Born Institute, Berlin, Germany.

Laser Molecular Spectroscopy and Molecular Liquids

Ionel I Mangalagiu is a Professor in department of Organic Chemistry at “Al.I.Cuza” University of Iasi, Romania

Biologically active molecules, Chemosensors and Organic Chemistry

Dr. Feng is an expert in biochemistry and biophysics of metalloproteins. His laboratory is known for its use of multidisciplinary approaches to study molecular mechanisms of metalloproteins in medicine and toxicology. The laboratory is active in the use of cutting-edge approaches across the broad fields of chemistry, biochemistry, physics and chemical biology (including laser flash photolysis, pulsed EPR, computational chemistry and site-directed mutagenesis). The goal is to understand what the function of a biological relevant metal site is, how it goes about to achieve its function, and what factors dictate its function. His current primary research focus is on regulation mechanism of nitric oxide synthase (NOS), a flavo-hemoprotein responsible for biosynthesis of nitric oxide (NO), a ubiquitous signaling and effector molecule in mammalian cell biology. Recent studies of NOS proteins by Dr. Feng demonstrate that domain motions and interdomain docking play an important role in NOS isoform function by modulating key electron transfer processes. Molecular mechanisms of NOS regulation, once fully understood, are potentially key targets for development of selective new pharmaceuticals for treating a wide range of diseases that currently lack effective treatments. Dr. Feng has published more than 70 scientific manuscripts, is an active NIH reviewer and also serves as referee for NSF, AHA, the French National Research Agency and the Italian Ministry of Health.

Biochemistry, Biophysics and toxicology

Marc Le Borgne has completed his PhD at the age of 31 years from Nantes Atlantic University after Pharmacy studies (6 years). He is the director of EA 4446 B2C, a research group dedicated to Drug Design and Structural Optimization. He has published more than 61 papers in reputed journals and has been serving as an editorial board member of Journal of Enzyme Inhibition and Medicinal Chemistry (2009-2012) and Current Bioactive Compounds (2008). He gave some invited lectures abroad (Saarbrück, Oslo, Tromsø, Bergen, Debrecen, Sacramento, Helsinki, Oulu). He is developing bioactive small molecules (e.g. kinases and CYP inhibitors).

Drug Design and Structural Optimization.

Linghai Xie is a Professor of Organic/Polymer Materials Chemistry at Nanjing University of Posts and Telecommunications (NUPT). He obtained his PhD from Fudan University in June 2006. After this, he joined Nanjing University of Posts and Telecommunications (NUPT) and become a leader of the center for molecular systms & organic devices (CMSOD). He won the “NSFC Award” for Excellent Young Scholar in 2013. His research activities focus on Molecular Installing Technology (MIT), Attractor-Repulsor Theory (ART), Polygrid Wide-Bandgap Semiconductors, Organic Electrets for Memories and Memristors. He has published more than 130 papers in reputed journals and has been cited more than 1700 times.

Organic Chemistry, Polymer Chemistry, Materials Chemistry

Violina T Angelova has completed his PhD in 2004 from Bulgarian Academy of Sciences, Institute of Organic Chemistry with Centre of Phytochemistry, Sofia, Bulgaria. She is an Assistant Professor of Medical University of Sofia, Faculty of Pharmacy, Department of Chemistry. She has published more than 15 papers in reputed journals.

Organic Chemistry, Pharmacy

Silvia Antonia Brandán is a Faculty Biochemistry, Chemistry and Pharmacy, in Inorganic Chemistry Institute, University National of Tucumán (UNT), Tucumán, Argentina. She is Graduated in Chemistry (UNT); Chemical Engineer (UNT); PhD in Chemistry (UNT); Post-Doctorate in Alicante University, Spain. She is the Titular Professor of General Chemistry and Director of the Inorganic Chemistry Institute. She is the Editor Journal of Molecular Structure.

Biochemistry, Inorganic Chemistry and Pharmacy

Werner Paulus is exploring low temperature oxygen diffusion mechanisms in transition metal oxides. Oxygen doping, via topotactic reaction mechanisms while proceeding at ambient temperature is a powerful tool to access structural and electronic complexity in a controlled way. It also allows to better explore the underlying diffusion mechanisms on an atomic scale, having huge importance in solid state ionics, e.g. for the optimisation of battery materials, fuel cell membranes/electrolytes or sensors. Research activities cover synthesis methods from powder to large single crystals and to explore oxygen intercalation reactions in especially dedicated electrochemical cells on single crystals and polycrystalline electrodes by neutron and X-ray diffraction (synchrotron & laboratory), spectroscopy (XAFS, Raman, INS, IXS, NMR) combined with 18O/16O oxygen isotope exchange reactions and sophisticated data analysis (Maximum Entropy, twinning).

Research activities cover synthesis methods from powder to large single crystals and to explore oxygen intercalation reactions in especially dedicated electrochemical cells on single crystals and polycrystalline electrodes by neutron and X-ray diffraction (synchrotron & laboratory), spectroscopy (XAFS, Raman, INS, IXS, NMR) combined with 18O/16O oxygen isotope exchange reactions and sophisticated data analysis (Maximum Entropy, twinning).

Sakari Kulmala is professor of Analytical Chemistry in the Department of Chemistry, Aalto University.

Analytical Chemistry, Electrochemiluminescence and its applications

Venelin Enchev is professor of Theoretical Chemistry in the Institute of Organic Chemistry with Centre of Phytochemistry, Bulgarian Academy of Science.

Organic Chemistry, Physical Chemistry, Theoretical Chemistry, Cheminformatics and Computational Chemistry, Computational Chemistry, Tautomerism, Proton transfer reactions

PD Dr. rer. habil. Daniel A. M. Egbe was born in Mambanda Cameroon on the 20th of May 1966. He obtained his BSc in Physics and Chemistry (major: Organic Chemistry ) in 1991 at the University of Yaoundé Cameroon (presently known as University of Yaoundé I (UYI)- uy1.uninet.cm). He moved to the Friedrich-Schiller University of Jena Germany (uni-jena.de) in 1992, where he obtained a Masters and a Ph. D in Chemistry in 1995 and 1999, respectively. He completed his "Habilitation" in Organic Chemistry at the same institution in 2006, before spending postdoctoral stays at the Max Planck Institute for Polymer Research in Mainz, Germany (02/2006-08/2006), at the Technical University of Eindhoven in Holland (2006-2007) and at the Technical University of Chemnitz, Germany (2007-2008). Since 2009, he is a senior scientist the Linz Institute for Organic Solar Cells (LIOS) (lios.at) of the Johannes Kepler University of Linz, Austria (jku.at). His research interests are the syntheses and the study of structure-property relations of (semi)conducting organic and organic/inorganic (hybrid) materials (small molecules and polymers) finding applications in organic light-emitting diodes (OLEDs), organic photovoltaics (OPVs), organic field effect transistors (OFETs), CO2 reduction, etc. He is member of German Chemical Society (GDCh), Organic Electronics Association (OE-A), American Chemical Society (ACS), World University Service (WUS), german chapter (member of board of directors) (wusgermany.de). He is the initiator of the German-Cameroonian Coordination office (KBK-cameroon.net), initiator of ANSOLE, initiator and chairman of ANSOLE Germany e.V. (ansole.org). Since July 2012, he is consultant at ICTP (The Abdus Salam International Centre for Theoretical Physics, Trieste Italy) on energy issues. He speaks more than 5 languages.

His research interests are the syntheses and the study of structure-property relations of (semi)conducting organic and organic/inorganic (hybrid) materials (small molecules and polymers) finding applications in organic light-emitting diodes (OLEDs), organic photovoltaics (OPVs), organic field effect transistors (OFETs), CO2 reduction, etc.

Werner Lottermoser has completed his thesis work about neutron diffraction and magnetism of special silicates from Francfort University (Germany) and university lecturing qualification on Single Crystal Mössbauer Spectroscopy (SCMBS) in 1996 from Salzburg University (Austria). He is now working on sub-nanometric imaging, nanomaterials and materials for industrial applications. He has published more than 65 papers in reputed journals and 150 abstracts and has been serving e.g. for one year as a referee board member at the Journal of Physical Chemistry A. Recently, he was awarded the Austrian Staatspreis for Innovation together with AB-Microelectronics, Salzburg

Materials Science and Mineralogy

Nina Dimcheva graduated from the University of Sofia (M.Sc. in Chemical Physics, 1990) and obtained her Ph.D. in Physical Chemistry at the University of Plovdiv (2001). Since mid-2006 she is Associate Professor of Physical Chemistry in the same department, The University of Plovdiv, Bulgaria. Her research interests are focused on the catalytic activities and electrochemical characteristics of immobilized enzymes; electrodeposition of nano-clusters of noble metals on graphite/glassy carbon; modification of electrodes by electrically active enzymes and related studies aiming at the development of enzyme-based biocatalytic electrodes.

Electrochemistry, Heterogeneous catalysis, Immobilized oxidative enzymes, Enzyme-modified graphite and noble metals electrodes, Amperometric biosensors, Biofuel cells.

Mirosław Kwiatkowski in 2004 obtained Ph.D. degree at the Faculty of Fuels and Energy, AGH University of Science and Technology in Krakow, in the discipline: technology of chemistry. Currently he is working an assistant professor at the AGH University of Science and Technology, at the Faculty of Energy and Fuels. Main field of his interests is physical chemistry, mathematical modelling of the adsorption process, description of the porous structure, practical aspects of adsorption, an analysis of the influence of the production method on the formation of the porous structure of carbon adsorbents, numerical analysis, computer science, energy efficiency, renewable energies and problems connected with municipal waste management. His published work includes more than 40 papers in international journals and 72 conference proceedings. He is a member of the editorial board of internationals journals as well as a member of the Organizing Committee international conferences, and a regular reviewer in a reputable scientific scientific journals. Apart from scientific work Mirosław Kwiatkowski also does some teaching. Runs classes on computer science, numerical methods, chemistry and is a tutor of a student scientific society called “Green Energy”.

Main field of his interests is physical chemistry, mathematical modelling of the adsorption process, description of the porous structure, practical aspects of adsorption, an analysis of the influence of the production method on the formation of the porous structure of carbon adsorbents, numerical analysis, computer science, energy efficiency, renewable energies and problems connected with municipal waste management.

Yedira Prieto graduated of bachelor of Biochemistry in 2005 and MSc in 2010 (UH, Cuba). She acquired expertise in different areas, such as: purification and development of analytical techniques; in proteomic studies of expression stability in recombinant NS0 cell lines. Yedira Prieto developed and validated of chromatographic techniques for the Mab´s characterization and quantification. Yedira Prieto have expertise in mass spectrometric for characterization of proteins and oligosaccharide residues. The measurement expression levels of mRNA in recombinant NS0 cell lines are part of acquired knowledge. She have been serving as reviewer of Cytotechnology journal and Member of Cuban Society of Pharmacy dated 2011.

Purification and Development of analytical techniques; Proteomic studies of expression stability in recombinant NS0 cell lines

Joseph Pesek received his B.S. degree in Chemistry from the University of Illinois, Urbana and his Ph.D. in Analytical Chemistry from the University of California, Los Angeles. He did a one-year postdoctoral fellowship at UCLA before becoming Assistant Professor of Chemistry at Northern Illinois University. He moved to San Jose State University becoming Professor of Chemistry and has also served as Department Chair, and Dean for Graduate Studies and Research. He has over 225 publications, 3 books, 4 patents and has made over 200 presentations at a variety of symposia and meetings. He is one of the editors for the Journal of Separation Science.

Separation methods including high performance liquid chromatography (HPLC), LCMS, capillary electrophoresis, capillary electrochromatography and microfluidic chips. Chemical modification of surfaces used in separation methods. Metabolomics and proteomics.

Employed at Polymer Institute, Slovak Academy of Sciences in Bratislava. Served as elected member of the Presidium of the Slovak Academy of Sciences, President of the Slovak Chemical Society, Chairman of the Czecho-Slovak and Slovak National Committee of Chemistry for IUPAC. Corresponding member of the Central European Academy of Sciences and member of the Learned Society of the Slovak Academy of Sciences. Author or co-author of two monographs and 250+ scientific papers in extenso published in refereed periodicals, proceedings and chapters of books, as well as 60+ patents (four of them were licensed) - cited more than 2,000x. Presented over 110 invited plenary, key and main lectures, as well as over 900 regular lectures and poster contributions on symposia and conferences and during lecturing tours to over fourty countries. Elected „Slovak scientist of the year 1999“ and „Slovak innovator of the year 2001“.

Polymer sciences Separation Sciences HPLC

Dr Kamberi holds a double major in chemical engineering & industrial chemistry. She received her PhD from Oita University in Oita, Japan and completed postdoctoral studies at Stanford University in Palo Alto, California. Dr Kamberi has over 25 years of pharmaceutical experience with increasing levels of responsibility across functional disciplines, including analytical R&D, bioanalytical, pre-clinical research, quality control and stability. She is currently the director of Analytical Chemistry, Bioanalytical, Stability at Abbott Vascular in Santa Clara, California, a worldwide premier medical device organization. Marika is author/co-author of more than 50 papers published in peer-reviewed journals, conference proceedings, and book chapters, and of 10 US patents.

Analytical Chemistry, Biotechnology, GMP, Pharmaceutical Industry, Clinical Trials and Drug Development

Yoichiro Ito graduated from Osaka City University Medical School in Osaka, Japan, in 1958. He was a resident in pathology at Cleveland Metropolitan General Hospital in Cleveland and the Michael Reese Hospital in Chicago before returning to Osaka to work as an instructor in the Department of Physiology at Osaka City University Medical School. He joined the NHLBI as a visiting scientist in 1968. He has been a Medical Officer in the Laboratory of Technical Development, the Laboratory of Biophysical Chemistry, and currently, the Biochemistry and Biophysics Center. He received the FLC Mid-Atlantic Region's award for Excellence in Technology Transfer for high-speed countercurrent chromatography in 2010. Dr. Ito has published over 600 articles and holds 50 patents for his numerous chromatographic advances.

Dr. Ito's primary interest is in inventing methods of isolating, purifying, or analyzing materials of biomedical interest—including cells, macromolecules, and small molecular weight compounds—by means of counter-current chromatography and elutriation.

Dr. Farid Menaa (Bsc. BioEngineering ; Bsc. Biology and Physiology ; Msc. Genetics ; Master Gerontology/Geriatrics ; PhD Radiation Oncology/Gerontology (Paris, France, 2003) ; three international post-doctoral terms in Oncology, Dermatology, Stem cells, Hematology, Genomics ; MBA Entrepreneurship and MD candidate), is an experienced and skilled inter- and multi-disciplinary professional. During his career, Dr. Menaa followed complementary formations in Marine Biology (Caen, France), Pharmacy (Liege, Belgium), Biochemistry, Chemistry and Biophysics (California, USA), Business Development and Management (USA and Brazil). During his ongoing career, Dr. Menaa has mainly contributed to the identification and function of new human genes modulated by radiation ; Discovered a new signaling pathway after DNA damage ; Pointed out the link between the presence of stem cells, some of their genetic mutations, and the patient’s diagnosis and prognostic ; Identified genomic alterations in adult sickle cell anemia patients with stroke ; Developed new phytotherapeutic formulations against skin conditions ; Demonstrated the importance of various natural medicines in the prevention and/or treatment of diverse inflammatory-state and non-communicable diseases (NCDs) ; Contributed to the development and characterization of new nanomaterials ; Developped personalized translational medical strategies to diagnose and treat better and faster chronic pathologies. In 2009, Dr. Menaa was named Chief Scientific Officer (CSO) and R&D&I Executive Vice-Pressident (EVP) for Fluorotronics, Inc, CA, USA, the leading company in Fluorine-Carbon Spectroscopy. Dr. Menaa co-developped and applied this innovative green technology to Nanomedicine, Medicinal Chemistry, Nanotechnology, Oncology, Pharmaceutical and Life Sciences. Dr. Menaa is currently Chief Editor of Journal of Nanomedicine and Nanotechnology (http://www.omicsonline.org/editorialboard-nanomedicine-nanotechnology-open-access.php), among his other involvements for the advancement of Medicine, Sciences and Technology. Dr. Menaa is the member of the technical/scientific committee of a large number of international scientific events, in particular he successfully organized the “Target Meeting´s 1st World Nanomedicine and Nanobiotechnology Online Conference” (http://www.targetmeeting.com; 2013). Dr. Menaa is also member of several prestigious medical and scientific organizations (e.g. AACR, AAAS, ASCB, IRSCC, SPIE, RSC, ACS, ASH, ASHG, AAPS), and the editor, guest editor and reviewer of a large number of esteemed journals worldwide (>80 in Sciences , Medicine, Technology and Business Administration). Dr. Menaa has authored or co-authored more than 100 articles (including research and review articles, books, book chapters, textbooks, proceedings, pending patents) and has participated to over 200 scientific international events. Overall, the holistic concept of Dr. Menaa led him to contribute for various clinical and R&D&I projects at the interface of Oncology, Nutrition/Micronutrition, Aging/Anti-Aging, OMICS (mainly Genomics) and Nanotechnology, in order to prevent, implement early diagnosis, and develop efficient and safer therapeutic options, in particular to improve the outcome of cancer patients, stroke patients and delay the aging process while improving their life quality.

Nanomedicine,Nanobiotechnology,Nanotheranostics; Oncology, Gerontology, Dermatology, Stem Cells, Emerging Green Technologies, Personalized Medicine; Translational Medicine; Integrative Biomedicine; Innovation & Quality, Professorship, Entrepreneurship, Business Development/Management, Marketing.

Nico Anders has been working in the field of analysis and renewables since 2009. In 2010 he completed his studies in Chemistry at the Martin-Luther University Halle/Saale in the group of Prof. Dr. Wilhelm Lorenz with the final thesis “Analysis and occurrence of polycyclic aromatic hydrocarbons in household dust”. He has obtained his PhD at the TU Braunschweig in the group of Prof. Dr. Vorlop at Thuenen Institute of Agricultural Technology in technical chemistry. Since 2013 he is working as junior research group leader in the Aachener Verfahrenstechnik at the RWTH Aachen University. The focus of this group are analysis of lignocellulosic biomass, green analytical chemistry, conversion of lignocellulosic biomass and chromatographic separation.

Green analytical chemistry, green chemistry, chromatographic separation, sample preparation, ion chromatography, mass spectrometry, time of flight, lignin, fuels, hydrolysis, biomass characterization

Katsuhiro Maeda recieved his B.S. (1993), M.S. (1995), and Ph.D. (1998) degrees from Nagoya University. In 1998, he joined the Graduate School of Molecular Design and Engineering, Nagoya University, as Assistant Professor and was promoted to Associate Professor in 2002. He moved to Kanazawa University in 2008 and was appointed as a full Professor in 2015. He has published more than 80 original papers.

Polymer chemistry, Analytical Chemistry, Material Chemistry, Applied Chemistry

Prof. Ravi Bhushan has an expertise in enantiomeric resolution of compounds of pharmaceutical importance using liquid chromatography. So far, he has guided 28 doctoral and 50 Masters’ theses, published more than 230 research papers in international refereed journals and chapters in books and encyclopedia. He edited four Special Issues of Biomedical Chromatography on Chiral Resolutions as Guest Editor. He received Alexander von Humboldt fellowship of Germany in 1988, and European Economic Community Fellowship in 1992. He is an elected Fellow of the Royal Society of Chemistry, London, and Fellow National Academy of Sciences India, (FNASc). He received the ‘Outstanding Teacher Award’ of the year 2007 of IIT Roorkee, and Khosla Research Prize and Silver Medal of Univ of Roorkee.

Ravi Bhushan current interest includes enantioseparation with both achiral phases of chromatography in the absence of any external chiral species.

Dr. CAGLAR ANDAC is an Assistant Professor at the Department of Analytical Chemistry, Faculty of Pharmacy, Istanbul University. She studied Chemical Engineering, had Ph.D. and M.Sc. degrees at Istanbul University, Institute of Health Sciences, Faculty of Pharmacy, Department of Analytical Chemistry on drug analysis in pharmaceutical formulations and biological fluids by spectrophotometric and liquid chromatographic methods. She conducted post-doctoral research at Medical Center of Munich University, Institute of Laboratory Medicine Laboratory of Bio-Separation with a main focus of hyphenation of mass spectrometry with on-line sample processing between the years 2011-2013. She has researches and publications on drug analysis in biological fluids by liquid chromatography mass spectrometry, on-line solid phase extraction coupled liquid chromatography, multidimensional chromatography, spectrophotometry, spectrofluorimetry including validation, degradation and pharmacokinetic studies. She is also serving as reviewer for several reputed journals like Journal of Mass Spectrometry, Journal of Chromatography B, Luminescence, Journal of Fluorescence, Journal of AOAC International, Analytical Methods, Analytical Letters and some others.

Dr. CAGLAR ANDAC is eager to expand on knowledge in the field of Omics through both observation and experimentation methodologies. Her recent research interests are on hyphenated systems, fully automated sample processing, on-line sample processing coupled with liquid chromatography tandem mass spectrometry, two dimensional and multidimensional chromatography.

Pierre Falson got his PhD at the LYON University. He is a CNRS (National Centre for Scientific Research) Research Director, enzymologist and membrane proteins biochemist, co-leading the Drug resistance mechanism and modulation team in the BMSSI CNRS-UCBL1 Research Unit. PFhas published 54 publications, patented 6 inventions and licensed2 to CALIXAR, a startup which he co-founded. He was awarded in 1991 by the Maurice Nicloux prize from the French Society of Biochemistry and Molecular Biology, in 2010 and 2011 by the “National competition of innovative start-ups” and by the Innovation and Transfer Technology prize from theCNRS.

The “Drug Resistance Mechanism and Modulation” group is studying the molecular and cellular mechanism of multidrug ABC (“ATP-binding cassette”) transporters which are responsible for cellular resistance to multiple chemotherapeutics.

Arvi Rauk has completed his PhD from Queen’s University in Kingston, Ontario and Postdoctoral studies from Princeton University, Department of Chemistry. He has published more than 200 papers in reputed journals and has been serving as an Editorial Board Member of repute.

Dr. Arvi Rauk research interests are in the area of theoretical organic chemistry, with emphasis on free radical structure and reactivity, chiroptical properties, and orbital interaction theory

Shoujun Xu obtained his PhD in Chemistry from the Johns Hopkins University and received Post-doctoral training in Caltech and University of California at Berkeley. His expertise includes magnetic detection, spectroscopy and technology development. He invented the force-induced remnant magnetization spectroscopy (FIRMS) technique. Its high force resolution has enabled a wide range of applications in biochemical research. Multiple papers on prestigious scientific journals have been produced, and several patents have been either awarded or pending.

Dr. Shoujun Xu's research focuses on developing various magnetic-based techniques for molecular and cellular imaging and magnetic resonance imaging. The following is a list of research themes we are currently pursuing. This list will be updated upon the invention of new technologies like Force-Induced Remnant Magnetization spectroscopy (FIRMS), Scanning Magnetic Imaging (SMI), Laser-Detected Magnetic Resonance Imaging (LD MRI) and Atomic Magnetometry (AM)

Concepción González-Bello has obtained her Ph.D. at the University of Santiago de Compostela (USC, Spain) in 1994. She did two predoctoral stays in the University of Gent (Belgium) with Prof. Vandewalle and in the Scripps Research Institute (USA) with Prof. Nicolaou. After three years of postdoctoral stay in the University of Cambridge (UK) with Prof. Chris Abell, she joined USC as an Assistant Professor, and was promoted to Associate Professor in 2003 and obtained the Spanish habilitation to full Professor in 2011. She is a member of the ChemMedChem International Advisory Board and has published about 50 papers in reputed journals.

Research group: Biological Chemistry and Supramolecular. Design and synthesis of new antibiotics and herbicides, Study of biological processes by molecular dynamics, Solid Phase Chemistry: Combinatorial chemistry, development of processes catalyzed by organo-metallic compounds.

Dr. Kal Ramnarayan (Dr. Ram) is the Founder, President, Chief Scientific Officer of Sapient Discovery. Previously, Dr. Ramnarayan Co-founded Structural Bioinformatics, Inc and Cengent Therapeutics, Inc. As part of the senior management team, he participated in raising more than US$ 50M. His technology leadership results in several leads for targets like ALF, PTP1B, SHP-2, DER, TNFR, Her-2, ZAP-70, IKKB, CD45, NY2R amongst others. He has had several successful grants from DARPA and SBIR. He has collaborated extensively with GSK, Novartis, J and J, DuPont, several Japanese, European and American companies in projects for lead discovery. Prior to Structural Bioinfofmatics, Inc., Dr. Ram was Head of Computational Chemistry at ImmunoPharmaceutics Inc., where he designed numerous drug leads, including highly specific endothelin-A receptor antagonists. This became Sitaxsentan, currently in Phase III clinical development by Encysive Pharmaceuticals. Dr. Ramnarayan holds a PhD in molecular biophysics from the Indian Institute of Science, Bangalore and has multiple papers and patents and several other patents pending. He is on the Advisory Board of the IBM BlueGene Initiative, Strand Genomics, Polyclone Bioservices and Keck Research Institute. He is on the Editorial Board of Current Proteomics.

His technology leadership results in several leads for targets like ALF, PTP1B, SHP-2, DER, TNFR, Her-2, ZAP-70, IKKB, CD45, NY2R amongst others.

Alessandra Nurisso has completed her PhD in Structural Glycobiology from Grenoble University (France). In 2010, she joined the Pharmacochemistry Laboratory of the School of Pharmaceutical Sciences of the University of Geneva (Switzerland) as a Post-Doctoral Researcher in Computer-Aided Drug Design. She is currently Lecturer in Medicinal Chemistry at the University of Geneva, at the University of Grenoble, and, since 2013, Chair of Excellence of the University of Geneva (Switzerland). Her current research focuses on in silico driven strategies for the design of novel molecules targeting epigenetic enzymes

Her research interest includes studies on promising anticancer agents

Yanli Wang obtained her PhD in Computational Biology in 1995 from Peking University, China and completed Postdoctoral studies from the National Institute of Cancer and National Center for Biotechnology Information (NCBI) during 1995-1998. She is currently the lead scientist of NCBI, primarily responsible for managing the PubChem bioassay resource. She has published more than 40 papers in reputed journals.

Medicinal chemistry and drug discovery

Andreia Valente completed her Ph.D. in 2010 from the Université de Lille I (France) on the field of Polymerization Catalysis. Then she joined the Organometallic Group at Faculty of Sciences,University of Lisbon (Portugal) where she got a first post-doc position in synthesis of organometallic compounds for nonlinear optic applications, followed by a second post-doc in the field of medicinal inorganic chemistry. Sheis presently a researcher (academic)at the same Institution, directing now her efforts to the synthesis of new polymer-metal complexes as targeteddrug-delivery systems in view to cancer therapy. To this ending, A. Valente counts with a multidisciplinary and enthusiastic team.

Medicinal Chemistry and Drug Delivery System

Prof. Tepe recieved his PhD from the University of Virginia in 1998 with Prof. T.L. Macdonald and completed his post-doctoral studies with Prof. R.M. Williams at Colorado State University in 2000. Research in his lab is primarily focused on the synthesis and use of natural products and their analogues to interrogate proteasome-mediated signaling pathways. Using the new synthetic methods, drug-like derivatives of natural products are prepared and interrogated for their clinical significance in vitro, cell culture and animal models. For his academic drug discovery efforts aimed at multiple myeloma, he received the American Cancer Research Scholar award, Senior Award from the Multiple Myeloma Research Foundation in 2008, and Multiple Myeloma senior award in 2010, and the International Myeloma Senior Award in 2013.

His research program provides an interdisciplinary blend of synthetic and medicinal chemistry that includes the total synthesis of natural products, the discovery of new reactions, as well as the evaluation for their cellular mechanism and medicinal properties. Natural products are still the primary source for medicines, and marine sponge metabolites represent a highly diverse and complex class of natural products with remarkable biological activities. Our laboratory is focused on the total synthesis of marine sponge alkaloids, to examine their potent anti-cancer and anti-neurodegenerative properties.

Tatsuya TAKAGI has completed his Ph.D. at the age of 32 from Osaka University.At that time, he had been an Assistant Professor of School of Pharmaceutical Sciences, Osaka University for 5 years. Then, since 1993, he had worked for the Genome Information Research Center, Osaka University as an Associate Professor until he became a professor of Graduate School of Pharmaceutical Sciences, Osaka University in 1998. He has published more than 100 papers in reputed journals and serving as Chairman of Division of Structure-Activity Relationship of the Pharmaceutical Society of Japan.

Genome Information Research

Dr. Victor J. Hruby is a Regents Professor in the Department of Chemistry and Biochemistry at the University of Arizona. He received his PhD at Cornell University in Theoretical Organic Chemistry and did a Postdoctoral studies with Nobel Laureate Vincent du Vigneaud. He has been a professor at University of Arizona since 1968 where he has joint appointments in the Neuroscience Program, Medical Pharmacology, and Bio5 among others. Dr. Hruby’s research interests are in the chemistry, biophysics, molecular pharmacology, molecular biology of peptide hormones and neurotransmitters and their receptors, transduction systems and in the design, synthesis and bio evaluation of novel ligands for the treatment of degenerative diseases.

Professor Hruby’s research has been primarily in the chemistry, conformation-biological activity relationships, molecular mechanisms of information transduction and of molecular diseases associated with peptide hormones and neurotransmitters and their receptors that modulate health, disease and human behavior. Specific methods and approaches used in this research include: de novo design of biologically active peptides and peptidomimetics; peptide and peptidomimetic synthesis; asymmetric synthesis; design and asymmetric synthesis of novel amino acids; computational chemistry; conformational analysis using NMR, X-ray crystallography and other biophysical tools; combinatorial chemistry; conformation-biological activity relationships; the design, synthesis and biological evaluation of peptide and peptide mimetic ligands that affect pain, addictions, feeding behaviors, pigmentation, sexual behavior and motivation, glucose homeostasis, cancer and other biological effects; peptide mimetic design; and the structure-function of G-protein coupled receptors. The Hruby group also is developing new synthetic methodologies for the assembly of multimeric ligands for the detection and treatment of pain, cancer and other diseases; a new approach to design of ligands for disease states involving the concept of overlapping pharmacophores to address several receptors simultaneously in a single molecular ligand. Professor Hruby has published over 1000 articles, reviews, chapters, commentaries and editorials and has over 25 patents and patent filings. Victor Hruby has received numerous awards and honors, including a Guggenheim Fellowship (1984), the Alan E. Pierce Award (now the Merrifield Award) (1993), a Senior Humboldt Fellowship (1999-2000), the American Chemical Society Ralph F. Hirschmann Award (2002), the Arthur C. Cope Scholar Award (2009), the Murray Goodman Award (2011), the ACS Medicinal Chemistry Hall of Fame (2012) and the Meienhofer Award (2012).

Thorsten Nowak completed his PhD from the University of Cambridge (UK) in the areas of aldol methodology and natural product synthesis. In 1996 he joint AstraZeneca where he worked on all stages of drug discovery from target to candidate selection in medicinal chemistry as team leader and project manager. His keen interest in new technologies motivated a career move from big pharma to platform technology business in 2012 when he joint C4X Discovery. In his current role he is responsible for all internal drug discovery projects at C4X Discovery as well as continued development of the technology in the context of application to drug discovery.

The spotlight in drug discovery and design has been firmly centred on “quality” and “efficiency” in an endeavour to improve productivity and reduce high development attrition rates. In particular, much attention has been focused on measured and predicted drug property optimization because this is expected to significantly impact both the quality and the efficiency of drug design. With such a dominating focus, it is right to ask if other important aspects of drug design are being generally overlooked by the medicinal and computational chemistry community. This presentation aims to make a case for the increasingly clear importance (and therefore necessary adoption) of conformational design in harmony with property optimization. It is argued that the impact of creatively applied conformational design based on a validated experimental foundation will lead to a number of benefits and can be far reaching. For example, limiting shape diversity whilst gaining a deep understanding of shape giving structural features presents a complementary approach to property based design. It will lead to a tighter integration of the highly complementary medicinal and computational chemistry workflows. And importantly, it will provide undoubtedly a driver to re-invigorate the development and creative exploitation of experimental methods aimed at describing and predicting the conformational behaviour of small molecules in solution. Hence, conformational design based on experimental evidence offers new drivers for innovation in drug discovery.

Marc Le Borgne has completed his PhD at the age of 31 years from Nantes Atlantic University after Pharmacy studies (6 years). He is the director of EA 4446 B2MC, a research group dedicated to Drug Design, Synthesis and Structural Optimization. He has published more than 60 papers in reputed journals and is serving as an editorial board member of Pharmaceuticals (since 2016). He gave some invited lectures abroad (Saarbrück, Duesseldorf, Oslo, Tromsø, Bergen, Debrecen, Sacramento, Helsinki, Oulu...). He is developing bioactive small molecules targeting kinases, efflux pumps and CYPs

Design, synthesis and structural optimization of functionalized small molecules as anticancer agents (CK2, Dyrks), efflux pump inhibitors (Pg-p, BCRP) and anti-infective agents (CYP51, vaccines). Some scaffolds developed: indole, naphthyridine, indeno[1,2-b]indole, steroids, peptidomimetics, polysialic acid.

Dr. Carsten Detering obtained his PhD in Physical Chemistry from the Freie Universitaet Berlin in Germany in 2001. He did his Post Doc at the University of Washington in Seattle where he worked on the application of docking software for nucleic acid drug targets and rational design of new inhibitors for a malaria project. In 2005 he came to BioSolveIT in Germany as an Application Scientist first, later filling the position of Senior Key Account Manager and Executive VP of Sales, North America, before moving back to Seattle as CEO of BioSolveIT Inc, the north American subsidiary of BioSolveIT.

He worked on the application of docking software for nucleic acid drug targets and rational design of new inhibitors for a malaria project.

Bin Xureceived his Ph.D. from Case Western Reserve University in 2004; and followed by postdoctoralstudies at Fred Hutchinson Cancer Research Center. Since 2011, he has been a tenure-track Assistant Professor in the Department of Biochemistry and Center for Drug Discovery at Virginia Tech. His research interests concern cell surface receptor-ligand binding, receptor signaling, novel ligand and receptor discovery, and translational structure-based and computer-aided ligand design with applications to novel peptide hormones and natural products relevant to diabetes, obesity,neurodegenerative diseases, and nanomedicine. He has published more than two dozens publications in premier international peer-reviewed journals.

His research interests concern cell surface receptor-ligand binding, receptor signaling, novel ligand and receptor discovery, and translational structure-based and computer-aided ligand design with applications to novel peptide hormones and natural products relevant to diabetes, obesity,neurodegenerative diseases, and nanomedicine

Mitsuji Yamashita was born in 1944 and has completed his PhD at the age of 27 years from Nagoya University, Japan, and postdoctoral studies from Toyota Science and Chemistry Research Institute, Japan, and Iowa State University, USA. He was a visiting professor of University of Massachusetts at Amherst, USA, and a researcher of Oxford University, UK, in 1994. He was promoted to be a professor of Graduate School of Science and Technology, Shizuoka University, Japan, in 1998 and retired at the age of 65 years old, and he is now a professor emeritus and specially-appointed professor of Shizuoka University, Japan. His research field is now focused on medicinal materials based on chemistry of carbohydrates and heterocycles. He has published more than 175 papers and patents as well as four books. Mitsuji Yamashita is now mainly concentrating in the research and development of phospha sugar antitumor agents and sugar dendritic Gd-DTPA MRI contrast agents for innovating in medical treatment for cancer patients.

By this research, novel multiple type low-molecular-weight antitumor agents of phospha sugar derivatives, which target IER5/Cdc25B and innovate in chemotheraputic treatment for cancer patients of various type of cancer cells, are developed. Sugar derivatives, whose oxygen atom in the hemiacetal ring is replaced by a nitrogen or a sulfur atom, etc., are called as pseudo sugars and well investigated. Among pseudo sugars phospha sugars in which the oxygen atom in the hemiacetal ring of sugars is replaced by a phosphorus moiety are not so well investigated in spite of important biological activities being expected for the pseudo sugar analogues. We have developed novel synthetic methodologies for preparing phospha sugar derivatives and constructed their compound library, and then preclinical evaluations have been carried out. Among the compound library of the phospha sugar derivatives, branched novel low-molecular-weight di- and tri-bromo deoxyphospha sugar derivatives (DBMPP and TBMPP) as well as some substituted phospha sugar analogues were found to exert novel, potential, and wide spectral antitumor activities by MTT in vitro evaluation method. The characterization and mechanism elucidation of these phospha sugar derivatives by flow cytometry and Western blotting showed that phospha sugars DBMPP and/or TBMPP enhanced the expression of cancer suppressors and suppressed the expression of cancer accelerators. Phospha sugar derivative TBMPP enhanced the expression of IER5 and then suppressed the expression of Cdc25B, which is the common and essential factor to act at the mitosis stage of the tumor cell cycles. Therefore, phospha sugar derivatives might induce apoptosis at G2/M stage and inhibit various kinds of cancer cells’ growth. In vivo evaluation for TBMPP against K562 cell transplanted to a nude mouse was checked visually to be successful. We are expecting that phospha sugars may be developed to be clinically useful novel antitumor agents.

Prof. Dr. Kreuter studied pharmacy from 1968 to 1971 at the Philipps-University Marburg, Germany. He did his Ph.D. from 1972 to 1974 at the Eidgenössische Technische Hochschule Zürich (ETH, Swiss Federal Institute of Technology) under the supervision of Prof. P. Speiser. His doctoral thesis was honoured with the ETH-Medal. He received his habilitation (D.Sc.) in 1982 at the ETH. In 1977 he worked as a postdoc with Prof. T. Higuchi in Lawrence, Kansas, U.S.A. and in 1979 with Prof. W. I. Higuchi in Ann Arbor, Michigan, U.S.A. In 1983 he was a guest professor at the University of Wisconsin, Madison, U.S.A. 1984 he became associate professor in pharmaceutical technology at the Johann Wolfgang Goethe-University in Frankfurt. Simultaneously he was offered the position of a full professor in pharmaceutical technology in Vienna but remained in Frankfurt. In 1990 he became full professor in Frankfurt. Twice he was dean, 1988/89 and 1997/98. In addition, from 1987 to 1990 he was Governor of the Controlled Release Society. He is recipient of the APV-Price 1981, the PPD Award of the Japanese Society of Powder Technology 2009, the Takeru and Aja Higuchi Honorary Lecture Award of the Japanese Academy of Pharmaceutical Sciences 2010, the Best Paper Award and the Most Cited Paper Award of the European Journal of Pharmaceutics and Biopharmaceutics in 2000 and in 2012, respectively, and the Jorge Heller Outstanding Paper Award of the Journal of Controlled Release 2009.

His research areas include drug-targeting, nanoparticles, drug transport across the blood-brain barrier using nanoparticles, microspheres, trans-dermal transport, polymeric drug delivery systems, adjuvants for vacccines, solid solutions, stability testing by microcalorymetry, and container materials. He has over 300 publications.

Wei Zhang, PhD Professor and Director of the Center for Green Chemistry Department of Chemistry University of Massachusetts Boston

Chemistry

Wei Li, Ph.D. Professor and Faculty Director of Instrument Facility University of Tennessee Health Science Center 881 Madison Avenue, room 561 Memphis, TN 38163 901-448-7532

Instrument Facility

Hiroshi Maeda is a world renowned expert in macromolecular therapeutics. He created the world first polymeric-conjugate drug, SMANCS, approved for treatment of hepatoma in Japan. Consequently, he discovered the concept of EPR effect of macromolecular-drugs, ubiquitous mechanism for solid tumor selective targeting of polymeric drugs. He received MS, University of California, Devis, Fulbright student, Ph.D., M.D., Tohoku University. He published more than 450 papers in reputed journals. He was awarded Lifetime-Achievement-Award at Royal-Pharmaceutical-Society, Princess-Takamatsu-Award in Cancer Research, Tomizo-Yoshida-Award, highest award of Japan-Cancer-Assoc., and also selected as most cited influential scientist in pharmacology by Thomson Reuters 2014, and H-index of 89.

His key areas of research includes concept of EPR effect of macromolecular-drugs, ubiquitous mechanism for solid tumor selective targeting of polymeric drugs. He created the world first polymeric-conjugate drug, SMANCS, approved for treatment of hepatoma in Japan

Frank M. Boeckler received his Ph.D. in Medicinal Chemistry from the University of Erlangen (Germany) in 2004 under supervision of Prof. Peter Gmeiner. He is specialized in computational chemistry and drug design, ranging from QM methods to in silico screening. In 2006, he joined Prof. Sir Alan R. Fersht at the MRC Center for Protein Engineering in Cambridge/UK as Marie Curie fellow and discovered there p53 mutant stabilizers as potential new cancer therapeutics. While working in Cambridge at the interface of experiment and theory, he focused on molecular biology and biophysics. In 2008, he was appointed as Professor (W2tt) for Bioanalytics at Ludwig-Maximilians University (LMU) Munich. In 2010, he moved to Eberhard Karls University Tubingen as Professor for Medicinal Chemistry/Drug Design, where he now heads the Laboratory for Molecular Design & Pharmaceutical Biophysics. Since 2014, he is also member of the Center for Bioinformatics Tubingen. He received several awards, including the Klaus-Grohe Award in Medicinal Chemistry, the Research Award of the Dornhecker Foundation and the PHOENIX Pharmazie-Wissenschaftspreis. In 2014, he was announced to be runner-up for the EFMC Prize for a Young Medicinal Chemist in Academia. His work is dedicated to understanding molecular interactions, particularly -hole bonding effects, as the foundation for chemical biology and drug research and to apply theoretical, chemical, biological, structural and biophysical methods to cancer research, particularly, for targeting the human kinome and the extensive p53 network.

• Understanding molecular interactions particular focus is halogen bonding, an innovative, bifunctional interaction. In drug research by generating tools, models, strategies and concepts for molecular design and fragment-based screening. Diversity-optimized and target-focused halogen-enriched fragment libraries (HEFLibs), use medicinal chemistry in combination with structural biology and computational chemistry for lead optimization of HEFLibs. • Develop and optimize biophysical and computer-aided techniques for screening, innovative assay formats, based on semi-automated titration, magnetic beads, and solid-phase synthesis by plate-spotting. With DEKOIS2.0, we have established tools for benchmarking of virtual screening strategies. • Extending the idea of molecular design to structured therapeutic peptides, developing a chemical tool-kit that can be used for selecting antibody-like, structured peptides, such peptides will be useful for therapeutic, diagnostic, analytical procedures, because they can be easily functionalized or linked to proteins, ligands, materials, radioisotopes, etc. • He is particularly interested in innovative therapeutic concepts in oncology, including individualized therapy und novel targets: e.g. p53 mutant rescue and therapeutic intervention in the p53 pathway; studying the paradigm of molecular chaperones for protein-(mis)folding diseases, targeting protein-protein interactions, kinase polypharmacology, epigenetic targets, etc.

Asunción Barbero was born in Burgos, Spain. She studied Chemistry at the University of Valladolid, and received her PhD degree at the same university working with Prof. Pulido. She joined Prof. Ian Fleming’s group at the University of Cambridge as Marie Curie fello for two years working in the study of stereocontrol in organic synthesis using silicon chemistry. She came back to Valladolid as Assistant Professor, was promoted to Associate Professor in 2001 and obtained the spanish habilitation to full Professor in 2012. In 2013 she was appointed as Coordinator of the Grade of Chemistry of the University of Valladolid. She has co-authored around 50 international scientific publications and has delivered several invited and plenary lectures. Her current interests include the study of the silyl-cupration of multiple bonds and its application to the synthesis of natural and related products.

Organic synthesis, synthesis of heterocycles, Organometallic synthesis, Synthesis of carbocycles, synthesis of natural products

Carlos Feleder was selected by the Italian Ministry of Health to review grant applications for biomedical research. He reviews grants in the fields of neuroscience, immunology, and endocrinology. Dr. Feleder servers as a Principal Investigator at the Albany Center for Computational Nano-Neuroscience at The State University of New York. He has done his M.D. from School of Medicine, University of Buenos Aires, Buenos Aires, Argentina and completed his PhD. from The Frauenklinik fur Experimentelle Endokrinologie, University George-August, Gottingen, Germany; and Department of Physiology, School of Medicine, University of Buenos Aires, Argentina

Dr. Feleder has a long-standing interest in uncovering the mechanisms underlying the body's response to immune challenges, i.e., how the central nervous system controls the physiologic functions that protect the body from the harmful effects of infectious agents. In 2008, Dr. Feleder was awarded a three year research grant totaling $231,000 from the National Institutes of Health (NIH) to study the effects of the spleen in managing fever.

Dr Laurent Désaubry is a CNRS research director in the University of Strasbourg in France (website: http://desaubry.u-strasbg.fr/) and professor at Tianjin University of Science and Technology (TUST) in China. He is currently editor and board member of Frontiers in Chemistry, Medicinal Chemistry and Advances in Oncology Research and Treatments. In 1992, he received a Ph.D. degree in medicinal chemistry from Strasbourg University. From 1992 to 1996, he worked as a postdoctoral fellow at SUNY at Stony Brook, USA. He made another post-doctoral internship in Prof. Pierre Chambon’s laboratory before to get a CNRS Research Senior Scientist at the University of Strasbourg-CNRS. He was promoted CNRS research director (corresponds to full professor) in 2014, and became also professor at TUST in 2015.

Medicinal Chemistry and Advances in Oncology Research and Treatments

Dr. Bhargava Karumudi is a research specialist at University of Illinois, Chicago in the field of medicinal chemistry. He has completed his postdoctoral in medicinal chemistry in 2014 at University of Illinois.

Organic Synthesis/Medicinal Chemistry, Chemical Biology, Chemistry of natural products with interesting biological activity, Natural products drug discovery, developing new probes to explore promising drug targets/photoaffinity labeling, LC-MS/MS.

Praveen S Hiremath is currently working as a Principal Scientist at Pharmaceutics International Inc Pii. He has completed Masters and doctoral studies and PhD in Pharmaceutics. Dr. Hiremath has worked in renowned Pharmaceutical companies like Astra Zeneca and Ranbaxy. Also he has Postdoctoral experience in Pharmaceutical drug delivery and formulation from Western University of Health Sciences, California, USA. Dr. Hiremath has published several research articles in peer reviewed international journals. He has extensively presented his research at international conferences/symposiums. Dr. Hiremath has been an invited speaker at international conferences. He has been invited to edit books in Pharmaceutical formulation and technology. Dr. Hiremath serves on editorial board of Journal of Bioequivalence and Bioavailability, Journal of Bioanalysis and Biomedicine and Research in Pharmaceutical Biotechnology. He is a full member of Sigma Xi Scientific Research Society and member of AAPS.

Oral drug delivery Pharmaceutical formulation development Controlled release drug delivery systems Pharmaceutical intellectual property (IP) Lipid based drug delivery systems Pharmaceutical technology Quality-by-design (QBD).

Rafat M Mohareb is Head of Organic Chemistry department Faculty of Pharmacy Modern Sciences and Arts University Professor of Organic Chemistry at Department of Chemistry faculty of Science Giza, Egypt. He got his Ph D Organic Chemistry on 1984 Cairo university Full professor of Organic chemistry 1994 Visiting Professor at UC Berkeley University State of California USA from 1999- 2002 Visiting Professor At Kuwait University 19951996. He was Humboldt fellows in Germany in 1988, 1989, 1993, 1995, 1998, 2003, 2006 and 2009. He received the price of encouragement of research work from Egypt 1995. He published more than 108 Scientific publications in International journals. He Supervised more than 5 PhD M Sc Theses.

Synthesis of new heterocyclic compounds with different pharmaceutical uses. Heterocyclizations of some Human Hormones followed by application of the synthesized compounds in Medicinal chemistry.Synthesis new dyes and their applications towards different fabrics.Recently his research focused on synthesizing antitumor agents.

Dr. Sahar Ahmed is an Assistant Professor at the Department of Pharmacognosy and Pharmaceutical Chemistry, College of Pharmacy, Taibah University, KSA. She is Currently on leave from the Department of Medicinal Chemistry, Faculty of Pharmacy, Assiut University, Egypt. Dr. Ahmed received her B.Sc. from the Faculty of Pharmacy, Assiut University, Egypt, and then her M.Sc. From the same Faculty. She subsequently got her Ph.D. from the Faculty of Pharmacy, University of Alberta, Canada in 2010 under the supervision of Dr. K. Kaur followed by one year of a postdoc at the same Faculty. She has participated in many international conferences and published 15 publications in international journals and one chapter book.

Her research areas include Organic Synthesis/Medicinal Chemistry, and Cancer Targeting Peptides.

Volkmar Weissig, Sc.D., Ph.D. is a Tenured Full Professor of Pharmacology and Chair of the Department of Pharmaceutical Sciences. Dr. Weissig received his B.S., M.S. and Ph.D. degrees in Chemistry and his postdoctoral Sc.D. degree in Biochemistry and Pharmaceutical Biotechnology from the Martin-Luther University in Halle (Germany). Combined he completed several years of postdoctoral fellowships at the Cardiology Research Center in Moscow (Russia), at the Academic Department of Medicine at the Royal Free Hospital School of Medicine in London (UK), at the Institute of Organic Chemistry at the Czechoslovakian Academy of Science in Prague (CSFR), at the College of Pharmacy and the College of Medicine at the University of Florida, Gainesville, FL and at Harvard Medical School and Massachusetts General Hospital in Boston, MA. Before joining the faculty at Midwestern University, Dr. Weissig was an Assistant Professor of Pharmaceutical Sciences at Northeastern University in Boston, MA. Dr. Weissig holds 16 patents and he has published 98 research papers, review articles and book chapters, mostly in the area of nano drug delivery systems. He also edited and published 8 books. He serves as the Associate Editor of the Journal of Liposome Research and he is member of several other Editorial Boards. In July 2009 Dr. Weissig was inducted into the World Technology Network as a Fellow. In October 2014 Dr. Weissig was elected President of the World Mitochondria Society.

Dr. Weissig’s major research interests lie in the areas of Mitochondrial Medicine and Pharmaceutical Nanotechnology. In particular, his laboratory has pioneered the design and development of mitochondria-targeted nano drug delivery systems, which have opened new strategies for mitochondrial gene therapy, for apoptosis-based anticancer chemotherapies and for controlling and manipulating the redox status of mammalian mitochondria.

Dr Joël Richard is currently Senior Vice President, Peptides in IPSEN (France). He is globally leading all the pharmaceutical development activities of both injectable and oral peptide-based products, including APIs and drug products, with major franchises in Oncology, Endocrinology and Neurology. Dr Richard has more than 25 years of experience in chemistry and biopharmaceutical R&D, including several previous global senior positions in various Biotech and Pharma companies, such as: - Vice President, Drug Product Development in Ipsen (France) (2008-2011), - Director, Pharmaceutical Development in Serono and Merck Serono (Italy, Germany) (2005-2008), - Vice President Research, and Europe R&D Director at Ethypharm (France) (2001-2004), - COO at Mainelab (France), a drug delivery company he co-founded, which was specialized in developing solvent-free processes for protein delivery systems (1999-2001). Dr Richard graduated from Ecole Normale Supérieure (Cachan, 1985). He has got a PhD in Materials & Colloidal Science (University of Paris VI, 1987) and “Habilitation à Diriger les Recherches” in Chemistry (University of Bordeaux I, 1994).

In the last 20 years, Dr Richard has focused his research activity on new formulation technologies and drug delivery systems (such as microspheres, nanoparticles, nanocapsules, chemically-modified proteins, supercritical fluid technology . . .), especially for injectable peptide and protein formulations. He has published 67 peer-reviewed scientific papers, 8 book chapters and 2 review editorials in various fields: polymers, colloids and interfaces, drug delivery, biodegradable microspheres, microencapsulation, supercritical fluids, protein formulations and post-translational modifications, nanoparticles, sustained-release formulations . . . He is the author of more than 120 international communications and 53 patent families.

MD and PhD from University of Zaragoza (Spain), Full Professor for Human Anatomy and Embryology at the Department of Neuroscience (UPV-EHU). He has supervised 20 Ph.D. works. He has been Invited Professor and Visiting Researcher at several European (Free University of Berlin, MCNN Birmingham) and Latinamerican universities (Chile, Valparaiso, Mendoza…). His main Research interests are in neuropathology and neurobiology of adaptive postnatal changes in the microvasculature of CNS in health and disease. He has been autor of 120 original papers and 33 reviewed book chapters. He is actively involved in cooperative networking in neuroscience research.

Neuropathology and Neurobiology of adaptive postnatal changes in the microvasculature of CNS in health and disease.

Rick Panicucci joined WuXi AppTec in February 2015 as the Vice President of Pharmaceutical Development Services. In this capacity, Rick provides scientific leadership for 160 scientists in Developability, Formulation Development, and GMP Manufacturing and is responsible for the execution of all Parenteral and Oral dosage form programs. He also maintains key client relationships and assesses new technologies through partnering or internal M&A capacity building. In addition to his position at WuXi, Rick currently serves as an Adjunct Professor at Massachusetts College of Pharmacy. Prior to WuXi, Rick was the Global Head of Chemical and Pharmaceutical Profiling (CPP) at Novartis from 2004 to 2015. His responsibilities included analytics, solid state chemistry and formulation development of all small molecule therapeutics in early development. He also helped develop novel drug delivery technologies for small molecules and large molecules including siRNA. Rick has also led groups in Formulation and Research and Development at Vertex Pharmaceuticals, Symbollon Pharmaceuticals, Biogen, and Bausch & Lomb.

Rick received his Ph.D. in Physical Organic Chemistry from the University of Toronto and had two post-doctoral fellowships at University of California at Santa Barbara and the Ontario Cancer Institute. Rick has written 33 publications on Formulations, Drug Delivery, and Drug Discovery.

R N Saha is Shri B K Birla & Shrimati Sarala Birla, Chair Professor (Senior Professor of Pharmacy) and Director of BITS Pilani Dubai Campus. In 2011 he has been awarded Shri B K Birla and Shrimati Sarala Birla Chair Professorship at BITS Pilani for contributions in teaching and research. He has vast experience in the field of Pharmacy especially in Pharmaceutics, novel drug delivery systems and Pharmacokinetics. He received “Pharmacy Professional of the Year 2013” Award given by Indian Association of Pharmaceutical Scientists and Technologists. He is also recipient of “The Best Pharmacy Teacher Award” for the year 2005, awarded by Association of Pharmaceuticals Teachers if India (APTI), in recognition of his contribution in teaching and research in the field of Pharmacy. He is also member of many scientific associations and societies like Association of Pharmaceutical Teachers of India (APTI); Indian Pharmaceutical Association (IPA); Indian Society of Technical Education (ISTE); Controlled Release Society Inc., USA; American Association of Pharmaceutical Scientists (AAPS), USA; American Chemical Society, USA; Controlled Release Society, Indian Chapter.

Pharmaceutics and Novel Drug Delivery Systems

Dr. Ruben Abagyan is a Professor in the Skaggs School of Pharmacy at the University of California, San Diego, which he joined in 2009. He received his Master’s degree in molecular physics from the Moscow Institute of Physics and Technology and his Ph.D. in molecular modeling and biophysics from the Moscow State University. At the European Molecular Biology Laboratory in Heidelberg he developed internal coordinate mechanics and docking approach (ICM). He built computational biology and chemistry facilities at the Skirball Institute in New York, Novartis Institute in La Jolla, Scripps Research Institute and San Diego Supercomputer Center, founded Molsoft Company, and served on boards of several companies. Currently Dr. Abagyan serves on international review panels for Institutes in Switzerland, UK and Hong Kong. He received two CapCure awards, and Princess Diana Award and medal in Sydney, Australia. R.A. authored and co-authored over 250 research papers and book chapters.

Ruben Abagyan studied physical chemistry and has completed his PhD in biophysics from the Moscow State University. He worked as a researcher, lab head or director of computational departments in a number of research organizations. His research interests include computational structural biology and cheminformatics, with a particular focus on modeling and docking screening, including target identification, polypharmacology and adverse effect prediction, and molecular modeling for G-protein coupled receptors, kinases and nuclear receptors. He has published more than 250 papers and book chapters in research journals and is serving as a number of international review panels and editorial boards.

Sung Wan Kim is currently a Distinguished Professor of Pharmaceutics and Pharmaceutical Chemistry and a Distinguished Professor of Bioengineering. He was Director of the Center for Controlled Chemical Delivery at the University of Utah from 1985-2006. He received his B.S. and M.S. at Seoul National University, and his Ph.D. in Physical Chemistry at the University of Utah (under Professor Henry Eyring). Dr. Kim is a pioneer in drug delivery research and has engaged in his research since 1974 in the areas of hydrogels, biodegradable drug conjugates, self-regulating drug delivery and stimuli sensitive polymers. He also worked extensively in medical polymers, especially blood compatible polymers. Dr. Kim’s present research includes design of novel polymers for the delivery of protein drugs, cells and genes. Dr. Kim has received numerous awards; among them are the Terumo Award – Japan (2014), AAAS Fellow (2014), Research Achievement Award-Pharmaceutical Sciences World Congress (2004), Rosenblatt Prize (2003), Ho-Am Prize (2003), AACP Volwiler Award (2002), American Association of Pharmaceutical Scientists (AAPS) Dale Wurster Award (1998), the Controlled Release Society (CRS) Founders Award (1995), and the Clemson Basic Biomaterials Award (1987). These awards are the highest scientific awards from their respective societies. He is the Founder and served as Co-Chairman of the International Symposium on Recent Advances in Drug Delivery, Salt Lake City, UT, 1983-2005. In 2006, Dr. Kim received an honorary doctorate degree from the University of Twente. From 2004 to present, Dr. Kim is a Hanyang Distinguished Professor at Hanyang University. Dr. Kim has published over 650 papers and owns 35 U.S. Patents. He has trained over 130 scientists from 10 countries.Dr. Kim Has Been Elected To Two U.S. National Academies: The Institute Of Medicine in 1999 (As Of 2015 Changed To The National Academy Of Medicine) And The National Academy Of Engineering In 2003.

Sung Wan Kim research interest is biomaterials, drug and gene delivery

Gabriele Sadowski is full Professor for Thermodynamics. Her main fields of research are thermodynamics of biological and pharmaceutical systems. She has published about 150 papers, is Chair of the German Working Party of Thermodynamics and member of the German Academy of Technical Sciences. 2011, she received the prestigious Leibniz award.

Thermodynamics of Biological and Pharmaceutical systems.

Head of Biomaterials Dept. - INNOVENT e. V., Jena

Research and development on biodegradable polymers and composite materials (synthesis of resorbable polylactones and their copolymers, degradable polyurethanes, glycosaminoglycan chemistry, resorbable bioactive and drug-containing implant coatings, surgical adhesives and other in situ curable materials, degradable materials for rapid manufacturing)

Dr. Afouna received his Ph.D. in Pharmaceutics & Pharma. Tech., University of Utah, Salt Lake City, UT, USA & Al-Azhar University, Egypt. He spent up to 3-years as a post-doctoral & research scientist at Department of Pharmaceutical Sciences, College of Pharmacy, University of Arkansas of Medical Sciences (UAMS), Little Rock, AR, USA. He is a highly motivated scientist (teacher, researcher) with extensive expertise in development and optimization of nanoemulsion, nanosuspension, gel/hydrogel & self-nanoemulsifying transdermal, topical, ocular & oral drug delivery systems. Focusing upon development of effective, safe and stable anti-glaucoma, anti-diabetic, hypolipidimic, and antihypertension drugs with great emphasize upon the effects of absorption promoters and other formulation-related factors, the physicochemical properties and chirality, upon the pharmacokinetics and biopharmaceutics of the drug. Moreover, he has focused upon development of non-clinical methodologies to assessing the topical bio-efficacy of various antiviral agents. Dr. Afouna has outstanding teaching capabilities & research experiences in pharmaceutical sciences, development and management of several valuable scientific research projects. He has orally presented many of his work in various inter/national meetings. Furthermore, he has authored & coauthored numerous recent research articles, review articles and chapters of books and textbooks. He is a co-founder College of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia where he worked as Professor for more than 6-years. Currently, Dr. Afouna is the professor & chairman of department of pharmaceutics & pharmaceutical technology, college of pharmacy, Al-Azhar University, Nasr City, Cairo, Egypt, 2012 – Present.

Development and optimization of nanoemulsion, nanosuspension, gel/hydrogel & self-nanoemulsifying transdermal, topical, ocular & oral drug delivery systems. Focusing upon development of effective, safe and stable anti-glaucoma, anti-diabetic, hypolipidimic, and antihypertension drugs with great emphasize upon the effects of absorption promoters and other formulation-related factors, the physicochemical properties and chirality, upon the pharmacokinetics and biopharmaceutics of the drug.

Prof Billa obtained his BPharm degree in 1993 from the University of Punjab, Pakistan and PhD in 2000 at the University of Science, Malaysia. He was appointed as Lecturer at the International Medical University in 2001 and also the Chief Scientists of a Bioequivalence Laboratory. In 2005, he joined the School of Pharmacy, University of Nottingham. In 2006 he was appointed as Associate Dean for research of the Faculty of Science and Professor in 2015. Prof Billa has supervised several PhD students and published extensively in peer-reviewed journals. He also serves as Editorial board member in a number of European and American Journals.

His research interest is in formulation of nanoparticulate drug delivery and gastrointestinal transit monitoring.

Maha Aboul Ela, graduate of Faculty of Pharmacy, University of Alexandria, Egypt. Ph D in Pharmaceutical Sciences (Pharmacognosy) 1991, University of Alexandria-Egypt and Technical University of Berlin-Germany. She had done her Postdoctoral fellowship, from School of Pharmacy, University of London, UK. She is Member of the American Society of Pharmacognosy. She is also Member of the editorial board of many international scientifi c journals. Currently, she is head of department of Pharmaceutical Sciences, Faculty of Pharmacy, Beirut Arab University, Lebanon.She is Expert in QA in Higher Education. Research interest: Phytochemistry, Phytotherapy, discovering new drugs from natural sources and participation in drug development through applying different pharmaceutical approaches, more than 55 publications in the fi eld of phytochemistry, medicinal plants and phytotherapy.

Research interest: Phytochemistry, Phytotherapy, discovering new drugs from natural sources and participation in drug development through applying different pharmaceutical approaches, more than 55 publications in the fi eld of phytochemistry, medicinal plants and phytotherapy.

Dr. Yousef Alomi, Head of General Administration of Pharmaceutical Care Administration, and Head of National Drug Information Center, MOH Saudi Arabia Dr. Alomi is a product of King Saud University confirmed with the degree of Bachelor of Pharmaceutical Sciences in the year 1992. After six-years of higher study, he earned his Master of Clinical Pharmacy from the same university in the 1998. He is an affiliated clinical instructor of Purdue University in the USA. He is adjunct assistant professor of King Saud University college of Pharmacy. Dr. Alomi was a member of Pharmacy Board at Saudi commission for health Specialties for 1998-2002 and 2008-2012 and Head of Pharmacy Accreditation committee in 2010-2012. He was team member of establishing 1st Pharmacy Residency Program in Saudi Arabia . In the year 2005 he obtained Board Certification of Pharmacotherapy Specialist (BCPS). In the year 2008, he obtained his diploma in business administration from American University in Egypt in 2007, and he obtained a Board Certification of Nutrition Support Pharmacy (BCNSP) in 2009. Dr. Alomi worked as clinical pharmacist in critical care area and nutrition support. He is He is establish and implement several programs at MOH Hospitals at first time; Clinical Pharmacy Program, Medication Safety Program, Pain Management Program, Anticoagulation Program and Pharmacy Infection Control, including 30 Adult and 20 Pediatrics Clinical Pharmacy Program; he is the founder of Mass Gathering Pharmaceutical Care in Saudi Arabia He became a member of advisory board of the Arab Pharmaceutical Journal in 2010. He became as Pharmacy Board Member of Saudi Commission of Health Care Specialities 2010-2013. He had several research in clinical Pharmacy and Pharmacy practice published in ACCP and ISPOR conferences, He had several presentations in the clinical pharmacy and pharmacy practice at several conference in and outside Saudi Arabia.

Pharmaceutics and Novel Drug Delivery, Clinical Pharmacy, Practice Pharmacy

B. B. Barik has completed his Ph.D. in 1993 from Jadavpur University, Kolkata, India. He is the Professor in the department of Pharmaceutics, College of Pharmacy, Jazan University, KSA. Earlier he worked as professor and head in the Univ Dept of Pharm Sci, Utkal University, Bhubaneswar, India and College of Pharmaceutical Sci, Berhampur, Odisha. He has published more than 50 papers in reputed journals and presented more than 100 papers in national and international conferences. He is serving as reviewer and editorial board member of reputed journals.

Novel Drug Delivery and Pharmaceutics

Luisa Fiandra has completed her PhD and postdoctoral studies from the Department of Biology of the University of Milan (Unimi), working in the field of transport physiology with a specific interest in permeability processes through intact epithelia and cell membranes. From 2010 to 2015 Luisa Fiandra has been a senior researcher at L. Sacco Hospital (Milan), where she contributed establish the Nanomedicine Unit, and scientific coordinator of the NanoMeDia Project, funded by Regione Lombardia (Italy). Today, LF is carrying out her research activity, mainly focused on the delivery of nanoformulated drugs across biological barriers, for the Department of Biomedical and Clinical Sciences “L. Sacco” of Unimi.

Nanomedicine, nanoformulation of drugs for breast cancer diagnosis and therapy and delivery of nanoformulated drugs across biological barriers.

Serena Mazzucchelli, PhD, research associate at the University of Milan. She received her bachelor degree in Biological Sciences in 2004, degree in Biology in 2006 and PhD in Biological Sciences in 2009 at the Department of Biotechnology and Biosciences (University of Milan-Bicocca-Italy). From 2009 to 2012 she has a post-doc fellowship at the Department of Biomedical and Clinical Sciences “L. Sacco” (University of Milan-Italy). From 2012 to 2015 she is researcher at the “L. Sacco” University Hospital. Today, SM is carrying out her research activity focused on the development of nanodevices for diagnosis and therapy of breast cancer at the Department of Biomedical and Clinical Sciences “L. Sacco” (University of Milan).

Biochemistry, nanobiotechnology and nanomedicine. SM research activity is focused on the study of nanoparticle interaction with tumor cells aimed at the development of nanodevices for diagnosis and therapy of breast cancer.

1978 and 1999 has completed his Ph.D and D.Sci. at the ages of 33 and 54 years from Zelinsky Instiute of Organic Chemistry, Moscow, Russia and Durmishidze Institute of Biochemistry and Biotechnology, Tbilisi, Georgia, respectively. 2006 up to date he is the head of laboratory of plant biopolymers at the Tbilisi State Medical University Institute of Pharmacochemistry. 1996 and 2002 he has been a visiting scientist at Utrecht University (faculty of pharmacy), The Netherlands, by University Scholarship and The Netherlands organization for scientific research (NWO) Scholarship Scientific Program, respectively. He has published more than 73 papers in reputed journals.

Biochemistry, biotechnology,biopolymers, Pharmacochemistry and pharmacy

Halina Abramczyk has completed his PhD from Technical University of Łódź, Poland, postdoctoral studies from Bielefeld University, Germany, and habilitation from Technical University of Łódź. She is the director of Laboratory of Laser Molecular Spectroscopy, Łódź University of Technology. He has published more than 190 papers in reputed journals, 7 books or chapters in books and has been serving as an editorial board member of Journal of Molecular Liquids. She has received a number of awards including the Marie Curie Excellence Chair, Fulbright, DAAD. She is a President of Polish Fulbright Alumni Association. She was a head of Marie Curie Excellence Chair, Max Born Institute, Berlin, Germany.

Chemistry,Laser Molecular Spectroscopy and Molecular Liquids

Bin Xureceived his Ph.D. from Case Western Reserve University in 2004; and followed by postdoctoralstudies at Fred Hutchinson Cancer Research Center. Since 2011, he has been a tenure-track Assistant Professor in the Department of Biochemistry and Center for Drug Discovery at Virginia Tech. His research interests concern cell surface receptor-ligand binding, receptor signaling, novel ligand and receptor discovery, and translational structure-based and computer-aided ligand design with applications to novel peptide hormones and natural products relevant to diabetes, obesity,neurodegenerative diseases, and nanomedicine. He has published more than two dozens publications in premier international peer-reviewed journals.

His research interests concern cell surface receptor-ligand binding, receptor signaling, novel ligand and receptor discovery, and translational structure-based and computer-aided ligand design with applications to novel peptide hormones and natural products relevant to diabetes, obesity,neurodegenerative diseases, and nanomedicine

Moinuddin Sarker, has been working as the Vice President of Research and Development and Head of Science Team at the Natural State Research (NSR), Inc., at Stamford, CT and the inventor of NSR ’s award winning technology to convert municipal waste plastics into liquid hydrocarbon fuel. He has an MSc (1992) and PhD degree in Chemistry from University of Manchester Institute of Science and Technology (UMIST), Manchester, UK (1996). During his research work, he carried out research in four different synchrotron radiation sources around the world: CRCL lab. Daresbury, Warrington, Cheshire, UK (1991-1996), Synchrotron Radiation Research Center (SRRC), Hsinchu, Taiwan, R.O.C (1996-1999), Berlin Electron Storage Ring Company for Synchrotron Radiation (BESSY II) (2000) and Advance Photon Sources (APS), Chicago, USA (2001-2004). He is a distinguished member of 30 professional organizations. In 2010, he received, the International Renewable Energy Innovator of the year Awards 2010 at Washington DC and presented by Association of Energy Engineers (AEE), USA. Currently, he serves as a President of AEE-CT Chapter (Association of Energy Engineers, CT Chapter) since 2012.

Chemistry and Plastics

Andreia Valente completed her Ph.D. in 2010 from the Université de Lille I (France) on the field of Polymerization Catalysis. Then she joined the Organometallic Group at Faculty of Sciences,University of Lisbon (Portugal) where she got a first post-doc position in synthesis of organometallic compounds for nonlinear optic applications, followed by a second post-doc in the field of medicinal inorganic chemistry. Sheis presently a researcher (academic)at the same Institution, directing now her efforts to the synthesis of new polymer-metal complexes as targeteddrug-delivery systems in view to cancer therapy. To this ending, A. Valente counts with a multidisciplinary and enthusiastic team.

Polymerization Catalysis

Joseph Pesek received his B.S. degree in Chemistry from the University of Illinois, Urbana and his Ph.D. in Analytical Chemistry from the University of California, Los Angeles. He did a one-year postdoctoral fellowship at UCLA before becoming Assistant Professor of Chemistry at Northern Illinois University. He moved to San Jose State University becoming Professor of Chemistry and has also served as Department Chair, and Dean for Graduate Studies and Research. He has over 225 publications, 3 books, 4 patents and has made over 200 presentations at a variety of symposia and meetings. He is one of the editors for the Journal of Separation Science.

High Performance Liquid Chromatography (HPLC) and Capillary Electrochromatography

Employed at Polymer Institute, Slovak Academy of Sciences in Bratislava. Served as elected member of the Presidium of the Slovak Academy of Sciences, President of the Slovak Chemical Society, Chairman of the Czecho-Slovak and Slovak National Committee of Chemistry for IUPAC. Corresponding member of the Central European Academy of Sciences and member of the Learned Society of the Slovak Academy of Sciences. Author or co-author of two monographs and 250+ scientific papers in extenso published in refereed periodicals, proceedings and chapters of books, as well as 60+ patents (four of them were licensed) - cited more than 2,000x. Presented over 110 invited plenary, key and main lectures, as well as over 900 regular lectures and poster contributions on symposia and conferences and during lecturing tours to over fourty countries. Elected „Slovak scientist of the year 1999“ and „Slovak innovator of the year 2001“.

Polymer sciences Separation Sciences HPLC

Dr Kamberi holds a double major in chemical engineering & industrial chemistry. She received her PhD from Oita University in Oita, Japan and completed postdoctoral studies from Stanford University in Palo Alto, California. Dr Kamberi has over 25 years of pharmaceutical experience with increasing levels of responsibility across functional disciplines including analytical R&D, bioanalytical, pre-clinical research, quality control and stability. She is currently the director of Analytical Chemistry, Bioanalytical, Stability at Abbott Vascular in Santa Clara, California, a worldwide premier medical device organization. Marika is author/co-author of more than 50 papers published in peer-reviewed journals, conference proceedings, and book chapters, and of 10 US patents.

Analytical Chemistry, Biotechnology, GMP, Pharmaceutical Industry, Clinical Trials and Drug Development

Rudolf Kapeller received his Dr. phil.in Chemistry from the University of Innsbruck. He worked as Analytical Chemist at the Bundesstaatliche bakt.-serol. Untersuchungsanstalt and since 8/1985 at the Austrian Agency for Health and Food Safety – Institute for Food Safety in Linz; from 5/1996 to 12/2015 as Head of the institute. He has been the author of various publications in the field of analytical chemistry and food safety.

Analytical Chemistry in the field of Food Safety; Chemometrics, Statistics, Method Validation and Automation (Author of Computer Programs in this field)

Michael John completed his PhD with Horst Kessler at the Technical University of Munich in 2004, and then spent 2 years with Gottfried Otting at the Australian National University, Canberra. Since 2007 he is lecturer and director of the NMR facility at the University of Göttingen. His list of publications includes more than 60 papers in peer-reviewed journals and 25 conference contributions

Anisotropic and Slice-Selective NMR

Dr. Farid Menaa (Bsc. Eng., Bsc. Bio., Msc. Genetics, Master Gerontology/Geriatry, PhD Radiation Oncology and Gerontology, EMBA Entrepreneurship and MD candidate), is an inter- and multi-disciplinary professional. Professor, Principal Investigator, Director, Consultant Editor, Reviewer, Event Organizer and Entrepreneur, Dr. Menaa earned his degrees with highest distinctions from prestigious French universities and institutions. Dr. Menaa followed a post-doctoral in Oncology as a NIH-fellow (San Diego, California, USA; 2004-2007). Subsequently, Dr. Menaa pursed his career in Dermatology, and Stem Cells as a DFG-Fellow (Wuerzburg, Germany; 2007–2009). Then, Dr. Menaa was promoted as Chief Scientific Officer and Vice-President R&D at Fluorotronics, Inc. (CA, USA; 2009-2010), a nanotechnology and fluorine chemical company. Eventually, Dr. Menaa was appointed Principal Investigator in Hematology and Genomics as a FAPESP-Fellow (São Paulo, Brazil; 2010–2012). During his career, Dr. Menaa also followed complementary formations (e.g. Medecine, Pharmacy, Biochemistry, Biophysics, Food Sciences and Technology, Marine Biology, Nano-Biotechnology, Bio-Computation, Bio-Statistics, Business Development and Management, Technological Innovation and Quality). Overall, Dr. Menaa was involved in various R&D projects in multiple areas of medicine/nanomedicine, pharmacy/pharmacology/toxicology, biology, stem cells/tissue engineering, genetics/genomics, fluorine chemistry/biochemistry, biophysics/biophotonics, food science, technology/nanotechnology, and business). His main current focuses are related to preventive, personalized, translational, integrative and nanomedicine, especially in the areas of oncology, regenerative medicine and gerontology, in order to prevent and implement early diagnosis and efficient therapy. Dr. Menaa has a strong experience with teaching, research and development, supervision, edition, leadership, coaching, consulting, event organizations, scientific & medical collaborations in several countries. Dr. Menaa is, among others, the leading organizer of the Target Meeting´s 1st World Nanomedicine and Nanobiotechnology Online Conference 2013 (http://www.targetmeeting.com), co-organizer of “Nanomaterials Conference” 2013 (Beijing, China) and 2014 (Shenzhen, China), member of the technical committee of the “3rd ScienceOne Conference on Drug Discovery and Development” 2014 (Dubai, UAE). Dr. Menaa is a member of several prestigious organizations (medical and scientific societies), editor, guest editor and reviewer of a large number of esteemed journals worldwide (>50) (e.g. Current Medicinal Chemistry, International Journal of Nanomedicine, Current Organic Chemistry). Among them, he sits on the prestigious editorial boards of Current Drug Therapy (for which is also the lead guest editor of a special issue on nano-pharmaceuticals), Journal of Nanomaterials & Molecular Nanotechnology (JNMN) (for which he is also a guest editor of a special issue on graphene), Journal of Biomaterials and Nanobiotechnology (JBNB), and Journal of Nanomedicine and Biotherapeutics Discovery (JNBD). Dr. Menaa authored and co-authored more than 100 publications (including peer-reviewed ISI research and review articles, books, book chapters, conference proceedings, patents). Dr. Menaa is often invited as a speaker, keynote/featured speaker and (co-)chairman to reputed world congresses and institutions, where he is offering speeches in various areas of medicine, sciences and technology. During his spare time, Dr. Menaa enjoys family, arts, sports and travelling.

Nanomedicine,Nanobiotechnology,Nanotheranostics; Oncology, Gerontology, Dermatology, Stem Cells, Emerging Green Technologies, Personalized Medicine; Translational Medicine; Integrative Biomedicine; Innovation & Quality, Professorship, Entrepreneurship, Business Development/Management, Marketing.

Professor Jin-Ming Lin received his BA degree at Fuzhou University in 1984 and received a PhD at Tokyo Metropolitan University in 1997. He had studied and worked in Showa University and Tokyo Metropolitan University during 1992-2002. He was selected as “100 Talented Researcher Program” for Chinese Academy of Sciences at 2001 and worked in Research Center for Eco-Environmental Sciences, Chinese Academy of Science during 2002-2004. He is currently a professor of Tsinghua University since 2004. He is a Deputy General-in-Secretary of Chinese Chemical Society, a member of council of Chinese Society for Chromatography Science, and service as Editorial Board for six international journals. He received more than 10 awards for his contributions in chemiluminescence and separation science. He is the author and co-author of 288 original research papers published in international journals, 28 reviews, 4 books and 41 patents.

Microfluidic device for cell analysis, Ultra weak chemiluminescence and chemiluminescent immunoassay, and sample pretreatment.

Bibliography: Prof and Dr Hideharu Shintani has received his PhD in Kyoto University during the period of 1972-1977. 1977-2008, He has been working for Government Official at National Institute of Health Science, Department of Medical Devices, Ministry of Health､Labor, Welfare. 2009-today, he is working as guest professor in Chuo University. He has successfully completed his Administrative responsibilities as Japan delegate of ISO TC 198　and ICH. His research has included sterilization, analytical chemistry, and safety of medical devices. Based on these research and fellowship training he has received several awards and honors, such as Award of Society for Biomaterials & Artificial Organs. He is serving as an editorial member of several reputed journals like Pharmaceutical Regulatory Affairs & expert Reviewers for journals like Biocontrol Science. He has authored Bioinstrumentation and Biosensors, 1990, Ohio Science Workbook Polymers, 1994, Analytical Applications of Immobilized Enzyme Reactors, 1994, Sterilization Systems 1995, Adsorption and its Application in Industry and Environmental Protection, 1998; Handbook of Analytical Application of Capillary Electrophoresis, 1996. Sterilization and Disinfection by Plasma –Sterilization Mechanisms, Biological and Medical Applications, 2011 research books. He is a member of Society for Biomaterials & Artificial Organs, Society of Antibacterial and Aantifungal Agents, Society of Analytical Chemistry, Society of Pharmaceutical Science.

Sterilization, Solid Phase Extraction, HPLC,
Analytical Chemistry,
Pharmaceutical Science,and Sterilization Validation.

Dr. Paraskevas D. Tzanavaras received his PhD in Analytical Chemistry in 2003 from the Department of Chemistry of the Aristotelian University of Thessaloniki, Greece. Since 2003 his is a Lecturer of Analytical Chemistry at the same department. His is Editor of the Analytical Chemistry section of the international journal Central European Journal of Chemistry and Assistant Editor on Flow Injection Techniques of Analytical Letters. He has published more than 60 scientific papers in international refereed journals and he is an active reviewer for more than 40 international journals.

Automated sample preparation by coupling sequential injection SI to separation techniques HPLC, CE, GC Use of monolithic stationary phases in LC and low-pressure setups Development of novel methods for the derivatization and analysis of thiols in various matrices

Assoc. Prof. Dr. Ismail Murat Palabiyik graduated from Faculty of Pharmacy, University of Ankara and obtained PhD from Department of Analytical Chemistry, Facult of Pharmacy, University of Ankara. Currently, he is working in same department. His current researches are synthesis and characterization of nanoparticles, DNA – drug interactions, investigating of anticancer effects of natural plant compounds, developing analytical techniques for drug analysis from dosage forms and biological fluids using with capillary electrophoresis, high performance liquid chromatography, spectrofluorimetry and UV spectrophotometry. Beside this, for investigating effects of experimental factors on analysis in HPLC and CE methods, he utilized Response Surface Methodology (RSM). Also, he is specialized in chemometry and worked one year in department of pharmacology and studied diabetes treatment. He is a Visiting Scholar, Katholieke Universiteit Leuven, Faculty of Pharmacy, Laboratory of Pharmaceutical Chemistry and Drug Analysis and worked with Professor Jos Hoogmartens group in liquid chromatographic column characterization. During his MSc and PhD period, he took a fellowship from TÜBİTAK – BİDEB, The Scientific Research and Technological Council of Turkey. His PhD thesis was awarded by University of Ankara. He is an editorial member of Pharmaceutica Analytica Acta and Pharmaceutical Regulatory Affairs:Open Access. He is a reviewer for journals like Journal of Pharmaceutical and Biomedical Analysis, Journal of AOAC International, Talanta, Journal of Liquid Chromatography & Related Techonogies, Spectrochimica Acta Part A.

1. Synthesis and Characteriztion of Nanoparticles, DNA – Drug interactions. 2. Investigation of anticancer effect of natural plant compounds. 3. Drug Analysis in Dosage Forms and Biological Samples: Development and validation of new analysis methods for simultaneous determination of drug mixture using capillary electrophoresis, high performance liquid chromatography, spectrophotometry and spectrofluorimetry. 4. Chemometry: Simultaneous determination and analysis of drug mixture using chemometric techniques (Classical Least Squares, Inverse Least Squares, Principal Component Regression, Partial Least Squares. 5. Method Optimization: Using statistical and mathematical techniques (Response Surface Methodology, Artifical Neural Network, etc.) for developing, improving and optimizing processes and interpreting the relationship between response and factor effects.

Dr. CAGLAR ANDAC is an Assistant Professor at the Department of Analytical Chemistry, Faculty of Pharmacy, Istanbul University. She studied Chemical Engineering, had Ph.D. and M.Sc. degrees at Istanbul University, Institute of Health Sciences, Faculty of Pharmacy, Department of Analytical Chemistry on drug analysis in pharmaceutical formulations and biological fluids by spectrophotometric and liquid chromatographic methods. She conducted post-doctoral research at Medical Center of Munich University, Institute of Laboratory Medicine Laboratory of Bio-Separation with a main focus of hyphenation of mass spectrometry with on-line sample processing between the years 2011-2013. She has researches and publications on drug analysis in biological fluids by liquid chromatography mass spectrometry, on-line solid phase extraction coupled liquid chromatography, multidimensional chromatography, spectrophotometry, spectrofluorimetry including validation, degradation and pharmacokinetic studies. She is also serving as reviewer for several reputed journals like Journal of Mass Spectrometry, Journal of Chromatography B, Luminescence, Journal of Fluorescence, Journal of AOAC International, Analytical Methods, Analytical Letters and some others.

Dr. CAGLAR ANDAC is eager to expand on knowledge in the field of Omics through both observation and experimentation methodologies. Her recent research interests are on hyphenated systems, fully automated sample processing, on-line sample processing coupled with liquid chromatography tandem mass spectrometry, two dimensional and multidimensional chromatography.

Dr Wahajuddin has completed his postdoctoral research in 2014 at the University of North Carolina (Chapel Hill, NC, USA). He is currently working as Scientist at Pharmacokinetics and Metabolism Division, CSIR Central Drug Research Institute (CDRI), Lucknow, India created by Ministry of Science and Technology, Govt. of India. He is also working as Assistant Professor, Pharmaceutical Sciences, at Academy of Scientific and Innovative Research (AcSIR) and as a Course Coordinator, MS (Pharm) in pharmaceutics, at National Institute of Pharmaceutical Sciences and Research, Raebareli under the aegis of Dept. of Pharmaceuticals, Govt. of India. He has won many prestigious awards including Young Pharmaceutical Analyst Award 2012 from Indian Drug Manufacturer’s Association, DBT- Cutting-edge Research Enhancement & Scientific Training (DBT-CREST) Award 2011-12 from Department of Biotechnology (Govt. of India), SERB-DST Fast Track Young Scientist Proposal Award 2011 from Dept. of Sc. & Tech. Govt. of India.

His areas of research interest include pharmacokinetics and bio-analysis of anti-malarial and anti-osteoporotic drugs and natural products using liquid chromatographic approaches.

Norman Dovichi holds the Grace-Rupley Professorship in the Department of Chemistry and Biochemistry at the University of Notre Dame. He received his BSc with a dual major in Chemistry and Mathematics from Northern Illinois University and his PhD in Physical Analytical Chemistry from the University of Utah, where he was Joel Harris’s first PhD student. He spent two years at Los Alamos Scientific Laboratory with Dick Keller. Since then he has held faculty positions at the Universities of Wyoming, Alberta, and Washington before taking his current position at Notre Dame. Dovichi has graduated 58 PhD students, has published over 275 papers, holds seven US patents, and has given over 350 invited talks. He has served on the editorial advisory boards of 16 journals and now serves as Associate Editor for Analytical Chemistry. He holds an honorary professorship with the Dalian Institute of Chemical Physics, Chinese Academy of Sciences.

research interests are: bioanalytical chemistry, single cell analysis, capillary electrophoresis, and developmental proteomics.

Jin Seok Hur received his Ph.D. degree in Chemical Engineering at Purdue University in 2006. After, he joined Novasep in US as a process development scientist and became the R&D manager in 2008. From Sep 2011 to Dec 2013, he was responsible for the R&D and Pilot teams in Novasep at Pompey, France. Since he came back to Novasep US in Jan 2014, he has been responsible for the R&D and Technology.

His research interests have been in the area of downstream separation processes, especially, preparative chromatography and membrane. He has published several technical articles and presented seminars at academic and professional conferences.

Professor Zoltan Takats obtained his PhD from Eötvös Loránd University, Budapest, Hungary. He has worked as a post-doctoral research associate at Purdue University, Indiana, USA. After returning to Hungary, he served as Director of Cell Screen Research Centre and also as Head of Newborn Screening and Metabolic Diagnostic Laboratory at Semmelweis University, Budapest. Professor Takats was awarded the Starting Grant by the European Research Council in 2008 and he subsequently was appointed to a Junior Research Group Leader at Justus Liebig University, Gießen, Germany. He moved to the United Kingdom in 2012 and is currently a Professor of Analytical Chemistry, Director of Mass Spectrometry Research within Division of Computational Systems and Medicine, Deputy Head of Division of Computational Systems and Medicine. He has published over 100 peer-reviewed articles in the fields of analytical chemistry and translational medicine, with more than 3000 independent citations. Some of these were published in Science, Nature, PNAS and Angewandte Chemie International Edition. He is primary inventor of eight analytical methods including Desorption Electrospray Ionization and Rapid Evaporative Ionization Mass Spectrometry, which are commercially available from Prosolia Inc. and Waters Corporation. He is one of the founders of the field termed ‘Ambient Ionization Mass Spectrometry’. He was also the recipient of the prestigious Mattauch-Herzog Award of the German Mass Spectrometry Society and the Hungarian Star Award for Outstanding Innovators.

Mass Spectrometry

Graduated with an honour Master of Chemical Engineering from the Slovak Technical University in Bratislava. PhD Thesis at Polymer Institute, Slovak Academy of Sciences in Bratislava and Institute of Macromolecular Chemistry, Czechoslovak Academy of Sciences in Prague. DSc Thesis (allowed to submit only after political change in 1989) at Slovak Academy of Sciences and Slovak Technical University Bratislava. Employed at Polymer Institute, Slovak Academy of Sciences (PI SAS) in Bratislava since 1960. 1992-1995 elected member of the Presidium of the Slovak Academy of Sciences. Served as President of the Slovak Chemical Society, Chairman of the Czecho-Slovak and Slovak National Committee of Chemistry for the International Union of Pure and Applied Chemistry and as Member of the Board of the Federation of European Chemical Societies. Corresponding member of the Central European Academy of Sciences, Bucharest, Roumania, and member of the Learned Society of the Slovak Academy of Sciences in Bratislava, Slovakia. Former titular member of IUPAC Polymer division and Chairman of Subcommittee of molecular chararacterization of synthetic polymers. Topics: Thermodynamics and hydrodynamics of multicomponent polymer systems; liquid chromatography of synthetic polymers - author of five original methods for separation of complex polymer systems; preparation and application of microporous carbon fibers. Author or co-author of two monographs on liquid chromatography and 250+ scientific papers in extenso published in refereed periodicals (150+ in the Current Contents covered Journals), and in proceedings and chapters of books, as well as 60+ patents (four of them were licensed) - cited more than 2,000 times in SCI journals and monographs. Presented over one hundred and ten invited plenary, key and main lectures, as well as over 900 lectures short communications and poster contributions during congresses, symposia and conferences and during lecturing tours to over fourty countries. Elected „Slovak scientist of the year 1999“ and „Slovak innovator of the year 2002“.

Interest in molecular characterization of complex synthetic polymers and complex systems of synthetic polymers

Dr. Adolfo Iulianelli, Degree in Chemical Engineering, is a Ph.D. in Chemical and Material Engineering. Nowadays, he works at the Institute on Membrane Technology of the Italian National Research Council. He published more than 50 articles in international scientific ISI journals, more than 20 chapters in international books, author of one patent and a book and of more than 50 papers in proceedings of National and International Conferences. He is reviewer of more than 20 scientific ISI journals, Associate Editor of International Journal of Membrane Science & Technology, Editor of Journal of Membrane Science and Technology, Advances in Chemical Engineering and Process Technology, Journal of Fuels and Scientific World Journal as well as serving as guest editor for International Journal of Hydrogen Energy. His H-index is today equal to 22.

1) Hydrogen production technologies. 2) Reforming reactions of both derived of fossil fuels and renewable sources. 3) Membrane reactors. 4) Gas separation via inorganic membranes. 5) Fuel cells.

Professor Petr Mikulášek has completed his PhD at the age of 33 years from University of Pardubice (Czech Republic). He was appointed professor for the field of Chemical Engineering in 2003. Since discharge, he worked at the University of Pardubice, now as the Head of the Institute of Environmental and Chemical Engineering. Prof. Mikulášek is the author of more than 70 scientific articles and chapters in scientific books and author and co-author of more than 120 contributions to international and national conferences. He is concerned with pressure driven membrane processes with a focus on treatment and disposal of waste-water.

pressure driven membrane processes and waste-water management

Dr. H. Nadaroglu has completed her Ph.D. and M.Sc. degrees at Ataturk University, Graduate Institute of Sciences, Department of Biohemistry (Erzurum, Turkey) on Bioorganic Reactions using purified carbonic anhydrase isoenzymes. She is scientific expert on process development on bioremediation of waste water, some nanobiotechnological applications onto environmental pollution and some industrial enzyme applications onto food technology (clarification of fruit juice, hydrolyzation of phytate ext.). She has published more than 120 papers in the field of biochemistry,food technology and nanobiotechnology journals and conferences.

Biochemistry, Enzymes Purification and Characterization, Biotechnology, Green synthesis nano particules, immobilization of some industrial enzymes, synthesis magnetic nanoparticules, Bioorganic Reactions, Spectroscopic Techniques.

Current position: Assistant Professor at the chair of Chemical Technology and Environmental Protection, University of Novi Sad Faculty of Sciences

Research interest: Environmental Protection, Chemical Technology, Drinking Water Treatment Drinking water treatment is key scientific interest. Expertise in gas chromatography analysis of environmental samples for wide range of organic pollutants determination using GC/MS, GC/μECD and GC/FID. Experienced working in laboratory and pilot scale investigations, in particular relating to applying various drinking water treatment processes.

Dr. Bahtiyar OZTURK was born in Trabzon, TURKEY, in 1966. He received the B.Sc. and MSc degrees in Environmental Engineering from Ondokuz Mayis University, Samsun, Turkey, in 1987 and in1991, respectively, and the Ph.D. degree in Chemical and Gas Engineering from the University of Salford, Manchester, England, in 1997. In 1997, he joined the Department of Environmental Engineering, Ondokuz Mayis University, as a Lecturer and researcher. He became an assistant professor in 1997, an associate professor in 2008 and a professor in 2013.

His current research interests include membrane technology, membrane gas separation, and renewable energy.

Associate Professor Department of Chemical Engineering, Monash University, Clayton Campus

A/Prof Xiwang Zhang’ researches focus on development of novel functional materials and membrane processes for water and wastewater treatment and disinfection, particularly clean water production, resources recovery and energy generation from wastewater. The specific interests are listed as follow:  Fabrication of 1D, 2D and 3D photocatalysts;  Process design of photocatalytic oxidation for water treatment;  Fabrication of functional membranes, e.g. photocatalytic membranes, hybrid membranes;  Forward osmosis process for energy and resource recovery from wastewater;  Fabrication of Metal-Organic-Frameworks (MOFs) adsorbents;  Electrochemical oxidation process;

Current position: Associate Professor at the chair of Chemical Technology and Environmental Protection, University of Novi Sad Faculty of Sciences Education: •2010- PhD in Chemistry, University of Novi Sad Faculty of Sciences, Department of Chemistry, Biochemistry and Environmental Protection •2003 - BSc in Chemistry, University of Novi Sad Faculty of Sciences, Department of Chemistry

Environmental protection, chemical technology, remediation of contaminated water, soil and sediment, bioavailability of inorganic/organic pollutants in sediments/soils investigation, adsorption of inorganic pollutants on nanomaterials. Expertise in analysis of environmental samples for wide range of inorganic pollutants. Head of the Laboratory for the analysis of environmental samples accredited according to ISO 17025 protocols.

Dr. Pongsak Rattanachaikunsopon have earned his Ph.D. degree in Molecular Biology from Lehigh University, Pennsylvania, USA. Currently, he working as a Professor in the Department of Biological Science, Faculty of Science, Ubon Ratchathani University, Thailand.

Dr. Pongsak interested fields of research are Molecular Biology, Microbiology and Biochemistry. My present research focuses on searching for biological agents such as microorganisms and plants to use as alternatives to control animal and human diseases caused by pathogenic bacteria.

Dr. Parichat Phumkhachorn is working as an Assistant Professor in the Department of Biological Science, Faculty of Science, Ubon Ratchathani University, Thailand. Her main research of interest is in the field of Medical Microbiology and Immunology. My present research focuses on finding bacteriophages for use as prophylactic and therapeutic agents against pathogenic bacteria causing animal and human diseases.

Dr. Parichat Phumkhachorn main research of interest is in the field of Medical Microbiology and Immunology. Dr. Parichat Phumkhachorn present research focuses on finding bacteriophages for use as prophylactic and therapeutic agents against pathogenic bacteria causing animal and human diseases.

Dr. CAGLAR ANDAC is an Assistant Professor at the Department of Analytical Chemistry, Faculty of Pharmacy, Istanbul University. She studied Chemical Engineering, had Ph.D. and M.Sc. degrees at Istanbul University, Institute of Health Sciences, Faculty of Pharmacy, Department of Analytical Chemistry on drug analysis in pharmaceutical formulations and biological fluids by spectrophotometric and liquid chromatographic methods. She conducted post-doctoral research at Medical Center of Munich University, Institute of Laboratory Medicine Laboratory of Bio-Separation with a main focus of hyphenation of mass spectrometry with on-line sample processing between the years 2011-2013. She has researches and publications on drug analysis in biological fluids by liquid chromatography mass spectrometry, on-line solid phase extraction coupled liquid chromatography, multidimensional chromatography, spectrophotometry, spectrofluorimetry including validation, degradation and pharmacokinetic studies. She is also serving as reviewer for several reputed journals like Journal of Mass Spectrometry, Journal of Chromatography B, Luminescence, Journal of Fluorescence, Journal of AOAC International, Analytical Methods, Analytical Letters and some others.

Her recent research interests are on hyphenated systems, fully automated sample processing, on-line sample processing coupled with liquid chromatography tandem mass spectrometry, two dimensional and multidimensional chromatography.

Current position: Full Professor at the Chair of Chemical Technology and Environmental Protection. Education: •2005 - PhD in Chemistry, University of Novi Sad Faculty of Sciences, Department of Chemistry, Biochemistry and Environmental Protection •2000 – MSc in Chemistry, University of Novi Sad Faculty of Sciences, Department of Chemistry •1997 - BSc in Chemistry, University of Novi Sad Faculty of Sciences, Department of Chemistry

Water Analysis and Drinking Water Technology, Water and Sludge Treatment, Environmental Protection, Environmental Risk Assessment. Expertise in gas chromatography analysis of environmental samples for wide range of organic pollutants. Experienced working in laboratory and pilot scale investigations, in particular relating to applying various drinking water treatment processes.

Prof. Pranjal Chandra is currently employed as Assistant Professor and principal investigator in Department of Biosciences and Bioengineering, Indian Institute of Technology, Guwahati. He earned his Ph.D. from Pusan National University, South Korea and did post-doctoral training at Technion-Israel Institute of Technology, Israel. He has published over 40 research articles in reputed journals and 1 edited book (IET, United Kingdom). He is also a visiting scientist at IBST, South Korea. His work has been highlighted in the World news of Royal Society of Chemistry, Cambridge as "A new system for cancer detection” and also featured as a key scientific article in the Global Medical Discovery news Canada. He is recipient of many prestigious awards and fellowships such as; Ramanujan fellowship (Gov. of India), BK -21 and NRF fellowship of South Korea, Technion post-doctoral fellowship, Israel, University of Montreal Post-doc fellowship, Canada. He is also editorial board member of a dozen international journals including; World journal of methodology, USA; Journal of Biosensors and Bioelectronics, USA etc.

•Clinical Diagnostics (Cancer cells, DNA, RNA, bio-markers) using electroanalytical methods such as cyclic voltammetry, chronoamperometry, impedance spectroscopy. • Nano-biosensors (Aptamer, antibody, enzyme) based biological phenomenon investigation. •Porous silicon based label free self reporting optical nanosensors. •Microfluidics